MACDERMID INC
DEF 14A, 1995-06-26
MISCELLANEOUS CHEMICAL PRODUCTS
Previous: LORAL CORP /NY/, DEF 14A, 1995-06-26
Next: MARION MERRELL DOW INC, SC 13D/A, 1995-06-26




                          SCHEDULE 14A INFORMATION

           Proxy Statement Pursuant to Section 14(a) of the Securities
                 Exchange Act of 1934 (Amendment No.     )

Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]

Check the appropriate box:
[ ] Preliminary Proxy Statement         [ ] Confidential, for Use of the
                                            Commission Only (as 
                                            permitted by
                                            Rule 14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12

                             MacDermid, Incorporated

                   (Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
[X]  $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), or 14a-
6(i)(2) or Item 22(a)(2) of Schedule 14A.
[ ]  $500 per each party to the controversy pursuant to Exchange Act 
Rule 14a-6(i)(3).
[ ]  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 
0-11.
     1)  Title of each class of securities to which transaction applies:

     2)  Aggregate number of securities to which transaction applies:

     3)  Per unit price or other underlying value of transaction 
     computed  pursuant to Exchange Act Rule 0-11 (Set forth the amount 
     on which the filing fee is calculated and state how it was determined):
                                                                        
     4)  Proposed maximum aggregate value of transaction:

     5)  Total fee paid:


[ ]  Fee paid previously with preliminary materials.
[ ]  Check box if any part of the fee is offset as provided by Exchange 
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee 
was paid previously.  Identify the previous filing by registration 
statement number, or the Form or Schedule and the date of its filing.

     1)  Amount Previously Paid:
     2)  Form, Schedule or Registration Statement No.:
     3)  Filing Party:
                                                            
     4)  Date Filed:
                                                            















































<PAGE>
     (MacDermid)
     (Logo)
                          MACDERMID, Incorporated
                             245 Freight Street
                         Waterbury, CT. 06702-0671

                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                            TO BE HELD JULY 20, 1995

     The Annual Meeting of Shareholders of MacDermid, Incorporated 
("MacDermid") will be held at the Holiday Inn Waterbury, 63 Grand 
Street, Waterbury, Connecticut, on Thursday, July 20, 1995 at 3:30 P.M. 
EDT, for the following purposes:

     1.     To elect five directors to hold office until the next annual 
meeting and until their successors are elected and qualified;

     2.     To consider and act upon a proposal to approve the 
MacDermid, Incorporated 1995 Equity Incentive Plan; and

     3.     To transact such other business as may properly come before 
the meeting or any adjournment thereof.

     The Board of Directors has fixed the close of business on June 1, 
1995 as the record date for the determination of shareholders who will 
be entitled to notice of and to vote at the meeting.  

      You are requested to promptly vote, date and sign the enclosed 
proxy and return it in the enclosed postage-paid envelope at your 
earliest convenience prior to the meeting.  Because it is impractical to 
eliminate duplication, separate proxies are mailed to persons whose 
names are shown in more than one way on MacDermid's stock records.  
Therefore, you may receive more than one proxy.  Please vote, date, sign 
and return all proxies received.

     If you are an employee participating in MacDermid's Employee Profit 
Sharing or Employee Stock Ownership Plans, you will receive separate 
instructions covering shares held for your account in such plan or 
plans.

     Your proxy vote is very important.  Prompt return of all your 
proxies will minimize proxy solicitation expense, assure a quorum and 
avoid confusion and delay at the meeting.

                                By Order of the Board of Directors,

Waterbury, Connecticut             JOHN L. CORDANI
June 26, 1995                      Corporate Secretary


IN ORDER TO AVOID UNNECESSARY EXPENSE, we urge you to indicate voting 
instructions on the enclosed proxy and date, sign and return it promptly 
PRIOR to the meeting in the envelope provided, no matter how large or 
small your holdings may be.
<PAGE>
     (MacDermid
     (Logo)
                                 MACDERMID
                                Incorporated
                              245 Freight Street
                      Waterbury, Connecticut 06702-0671


                          PROXY STATEMENT GENERAL

     The accompanying proxy is being solicited by the Board of Directors 
of MacDermid, Incorporated ("MacDermid") for use at the annual meeting 
of shareholders of MacDermid and at any and all adjournments thereof 
(the "Meeting") to be held, pursuant to the accompanying Notice of 
Annual Meeting of Shareholders, at Holiday Inn Waterbury, 63 Grand 
Street, Waterbury, Connecticut on Thursday, July 20, 1995 at 3:30 P.M., 
EDT.

     Each holder of MacDermid's common stock (the "Common Stock") is 
entitled to one vote per share on each matter to be brought before the 
Meeting.  Valid proxies will be voted as specified thereon at the 
Meeting.  Any shareholder giving a proxy in the accompanying form (a 
"Proxy") retains the power to revoke it at any time prior to the 
exercise of the powers conferred thereby by (1) delivering written 
notice of such revocation to John L. Cordani, Corporate Secretary, 
MacDermid, Incorporated, 245 Freight Street, Waterbury, Connecticut 
06702-0671; (2) delivering to the Corporate Secretary a duly executed 
Proxy or other proxy form bearing a date subsequent to the date on the 
given Proxy; or (3) appearing at the Meeting and requesting to vote his 
or her shares in person.  Any shareholder who attends the Meeting in 
person will not be deemed thereby to revoke the Proxy unless such 
shareholder affirmatively indicates at the Meeting his intention to vote 
the shares in person.

     Unless a shareholder provides contrary instructions on a Proxy, all 
shares represented by the Proxy (if not revoked before such shares are 
voted) will be voted for the election of the nominees for directors 
named below, for approval of the MacDermid, Incorporated 1995 Equity 
Incentive Plan, and by the persons granted the proxies in their 
discretion on any other business properly to come before the Meeting.

     MacDermid has retained D.F. King & Co., Inc. of New York, New York 
("King") to assist with the solicitation of Proxies and the mailing and 
distribution of proxy material.  The anticipated cost of King's 
services, including reimbursement for expenses, is approximately $8,500.  
MacDermid will bear the cost of the solicitation of Proxies, which may 
include the reasonable expenses of brokerage firms and others for 
forwarding Proxies and proxy material to the beneficial owners of Common 
Stock of MacDermid.  In addition to the use of the mails, Proxies may be 
solicited by King and by regular employees of MacDermid personally or by 
telephone or telegram.  Votes will be counted by employees of Harris 
Trust Company of New York, New York ("Harris"), the Corporation's 
transfer agent.  Harris will also provide an Inspector of Election who 
will certify the votes at the meeting of shareholders.

     Only holders of Common Stock of record at the close of business on 
June 1, 1995 are entitled to notice of and to vote at the Meeting.  On 
that date there were 2,767,533 shares of Common Stock outstanding and 
entitled to be voted.  Holders of a majority of such outstanding shares, 
present in person or represented by proxy, will be necessary to 
constitute a quorum at the Meeting.  If a quorum is present, the 
affirmative vote of a majority of the shares present in person or 
represented by proxy at the Meeting will be necessary for the election 
of each nominee for director and for approval of the MacDermid, 
Incorporated 1995 Equity Incentive Plan.  Abstentions and broker non-
votes are counted for purposes of determining the presence or absence of 
a quorum.  Abstentions are counted in determining the shares represented 
at the Meeting with respect to each proposal presented to shareholders, 
but broker non-votes are not counted for such purpose.

     Any shares held for the account of a shareholder who participates 
in the MacDermid Dividend Reinvestment Plan will be voted automatically 
with the shareholder's other shares of Common Stock as directed by the 
shareholder on the enclosed Proxy.

     The approximate date on which this Proxy Statement and the 
accompanying Proxy are first sent to shareholders is June 26, 1995.  
MacDermid's Annual Report to Shareholders, containing financial 
statements for the fiscal year ended March 31, 1995, accompanies these 
proxy materials to each shareholder.



(EVERY SHAREHOLDER'S VOTE IS IMPORTANT)
Please complete, sign and return your proxy card in the enclosed 
envelope.





















<PAGE>
                                   ITEM 1

                            ELECTION OF DIRECTORS

     The Board of Directors, pursuant to the By-Laws, has fixed at five 
the number of directors to be elected at the Meeting.  Shares 
represented by Proxies will be voted for the election of the nominees 
for director listed below, unless otherwise indicated.  Each director of 
MacDermid shall serve until the next annual meeting and until his 
successor has been elected and qualified.  All the nominees are 
currently directors of MacDermid.

     Management has no reason to believe that any nominee named below 
will be unable to serve as a director.  If at the time of the Meeting a 
nominee should be unable to stand for election, it is the intention of 
the persons granted the Proxies to vote in their discretion for such 
person as may be designated as a nominee by the Board of Directors of 
MacDermid.

     Messrs. Walter F. Torrance, Jr., Robert F. Weltzien, and Francis M. 
White are retiring as Directors and will not be standing for re-election 
as Directors, posts in which they have served well and faithfully for 
many years.

     The following information has been provided by each director 
nominee.

                          -Nominees for Director-

HAROLD LEEVER  Mr. Leever joined MacDermid        (Full face photo of
in 1938.  He was elected President in 1954 and     Harold Leever will
Chairman of the Board in 1977.  Mr. Leever is      be placed here.)
active in a number of organizations concerned 
with education, health and youth development.
Mr. Leever has a B.S. degree in Chemical 
Engineering from Michigan State University. 

Principal occupation - Chairman of the Board of MacDermid

Director since 1947

207,035 shares - 7.48% (1)

Chairman of the Executive and Nominating Committees.

Age:  81

- ------------------------------------------------------------------------





<PAGE>
                        --Nominees for Director --


(Full face photo of         DANIEL H. LEEVER  Mr. Leever joined 
Daniel H. Leever will       MacDermid in 1982.  In 1989, he was 
be placed here)             appointed Senior Vice President and 
                            Chief Operating Officer.  In the    
                            following year, he was appointed President 
                            and Chief Executive Officer.  Mr. Leever 
                            attended undergraduate school at Kansas 
                            State University and the Graduate School at 
                            the University of New Haven School of 
                            Business.

Principal occupation -President and Chief Executive Officer of MacDermid

Director since 1989

124,803 shares - 4.38% (3)

Member of the Executive and Nominating Committees

Age:  46 

- ------------------------------------------------------------------------

DONALD G. OGILVIE - Mr. Ogilvie is the 
Executive Vice President of the American
Bankers Association.  He was from 1980 to 
1985 a Vice President of Celanese Corporation       (Full face photo of
and from 1977 to 1980 Associate Dean of Yale        Donald G. Ogilvie 
University's School of Organization and Management. will be placed here)
Earlier he held posts in the U.S. Department of 
Defense and in the Executive Office of the President
as Associate Director National Security and 
International Affairs in the Office of Management 
and Budget.  Mr. Ogilvie has a B.A. degree from Yale
University and an M.B.A. from Stanford University's
School of Business.

Principal occupation - Executive Vice President of American Bankers 
  Association

Director since 1986

708 shares - *(2)

Member of the Audit, Compensation, Executive and Nominating Committees.

Age:  52



<PAGE>
                       --Nominees for Director--

(Full face photo of           JAMES C. SMITH  Mr. Smith is Chairman of
James C. Smith                the Board and Chief Executive Officer of
will be placed here)          Webster Financial Corporation and its 
                              its subsidiaries, First Federal Bank of
                              Waterbury, Connecticut and Bristol Savings 
                              Bank of Bristol, Connecticut.  He also 
                              serves and has served since prior to 1987 
                              as President of Webster and First Federal.  
                              Mr. Smith is active in a number of 
                              organizations dedicated to enhancing the 
                              quality of life in the communities served 
                              by Webster.  Mr. Smith has an AB degree 
                              from Dartmouth College.

Principal occupation - Chairman of the Board and Chief Executive Officer 
of Webster Financial Corporation and its subsidiaries, First Federal 
Bank and Bristol Savings Bank.

Director since 1994

1,000 shares  - * (2)

Member of the Audit, Compensation, Executive and Nominating Committees.

Age:  46

- ------------------------------------------------------------------------

THOMAS W. SMITH  Mr. Smith is and since 1973      (Full face photo of
has been the President of Prescott Investors,      Thomas W. Smith will
Inc.  He is on the board of directors of Lawson    be placed here)
Products, Inc. and The New York City Technical 
College Foundation.  Mr. Smith has a B.A. degree 
from Miami University and an M.A. from the 
University of California at Berkeley.

Principal occupation - President of Prescott Investors, Inc.

Director since 1989

211,460 shares - 7.64%(4)

Chairman of the Audit and Compensation Committees and a member of the 
   Executive and Nominating Committees

Age:  67

- ------------------------------------------------------------------------

* Indicates less than 1% of the outstanding shares of Common Stock.

<PAGE>

Notes to Election of Directors

     (1) Includes 21,900 shares owned by his wife, Ruth Ann Leever, as 
to all of which shares Mr. Leever disclaims any beneficial interest, and 
5,520 shares held by MacDermid's Profit Sharing and Employee Stock 
Ownership Plans.  Mr. Leever has sole voting power with respect to 
179,615 shares.  The Bank of Boston Connecticut, as trustee of a 
revocable trust, may have or succeed to the rights to vote 150,275 
shares.  A portion of the information for Mr. Leever was obtained from 
his amended Schedule 13G dated February 13, 1995.  MacDermid has entered 
into an agreement with Mr. Leever that up to the greater of $522,988 or 
the then face amount of a life insurance policy held by MacDermid on Mr. 
Leever's life will be used to purchase a portion of his MacDermid shares 
upon his death.  The total purchases to be made are not to exceed the 
total of the state and federal estate taxes and funeral and 
administration expenses of Mr. Leever's estate.  The price per share of 
such purchase is to be the market price at the time of death.

     (2) Owner has sole investment and voting power.

     (3) Includes 8,973 shares held by MacDermid's Profit Sharing and 
Employee Stock Ownership plans, 7,500 and 20,000 shares which are 
subject to restrictions on transfer until May 30, 1998 and May 17, 1999 
respectively under the Special Stock Purchase Plan and 80,000 shares 
which may be acquired upon exercise of options granted under the Special 
Stock Purchase Plan.  Also includes 7,062 shares held in trust by Mr. 
Leever for his minor son and 202 shares owned by his spouse, as to both 
of which Mr. Leever disclaims beneficial interest.

     (4) Includes 201,012 shares held by partnerships in which Mr. Smith 
is a general partner and 5,000 shares held by Prescott Investors, Inc. 
Employee Profit Sharing Plan, as to all of which Mr. Smith shares voting 
and investment power.  A portion of the information for Prescott 
Investors, Inc. is taken from its amended Schedule 13D dated August 3, 
1990.



                            COMPENSATION COMMITTEE
                       REPORT ON EXECUTIVE COMPENSATION

     The Compensation Committee has furnished the following report on 
executive compensation in the fiscal year ended March 31, 1995.

EXECUTIVE OFFICER COMPENSATION

     The Compensation Committee is primarily responsible for 
implementing MacDermid's overall executive officer compensation policy 
of compensating MacDermid's executive officers with base salaries 
competitive with those of comparable companies, rewarding exceptional 
performance where appropriate and providing incentive for future such 
performance through incentive bonuses and equity incentives.  
MacDermid's executive compensation has three basic components:  base 
annual salary, incentive bonus and equity incentives (long term 
compensation).

     In establishing levels of annual salary, incentive bonus and equity 
incentives, the Committee generally considers the following factors: (i) 
the compensation policies and practices of competitive and other 
businesses, (ii) the level and degree of responsibility of each officer, 
(iii) the level of compensation and equity incentives which would be 
required to attract and hold qualified and experienced officers, (iv) 
the individual and collective performance and achievements of 
MacDermid's executive officers and (v) MacDermid's performance, growth 
and achievements relative to the industries in which MacDermid competes.  

     MacDermid uses a comparator group of companies, some of which are in 
the specialty chemicals industry, (the "Comparator Group") to serve as a 
factor for determining the appropriate cash and equity incentive components 
of the program.  The companies in the Comparator Group are selected based 
upon their similarity to  MacDermid, as determined by total revenue and
other relevant factors.  Earnings trends, return on equity and other
performance measures are compared.  The size and composition of the
Comparator Group may change from year to year.  The Comparator Group 
differed from the group of companies included in the Media General 
Specialty Chemical stock index used in the Comparative Stock Performance 
graph on page 9.  The Media General Specialty Chemical stock index, 
which consists of approximately 70 companies, is too unwieldy to use for 
compensation purposes because of the large number of companies and their 
disparate compensation practices.  The Comparator Group is not used in 
the performance graph principally because of the need to maintain 
consistency in the indices or peer groups used in the graph.

     Before considering the other compensation factors discussed above, 
the Committee targets base annual compensation at a level which, 
together with incentive bonuses, would provide cash compensation to 
individual executives at below median market compensation levels for 
poor corporate performance, at median market compensation levels for 
good corporate performance, and above median market compensation levels 
for excellent corporate performance.

     Executive officers were eligible to receive incentive bonuses 
pursuant to MacDermid's Executive Incentive Bonus Plan, the purpose of 
which is to motivate executive officers to use their best efforts to 
enhance shareholder value through improvements in MacDermid's financial 
performance.  The Committee uses a formula as a guide in determining the 
initial amount of the executive incentive bonus.  The formula utilizes 
the following three factors, each of which is given equal weight: (i) 
the increase in consolidated earnings per share averaged over the most 
recent two-year period (the "EPS Change"), (ii) the relationship of 
net earnings to net sales ("ROS") and (iii) the relationship of net 
earnings to average shareholders' equity ("ROE").  An incentive bonus 
is paid with respect to a particular factor only if the EPS Change, ROS 
or ROE equal or exceed 3%, 4% and 14%, respectively.  The amount of 
incentive bonus that is actually paid to executive officers is subject 
to adjustment by the Committee.

     During the fiscal year ended March 31, 1995 MacDermid's executive 
officers were eligible to receive equity incentives under the MacDermid 
Special Stock Purchase Plan (the "Plan").  The Committee administers 
the Plan, which was approved by MacDermid's shareholders in 1992, and 
awards equity incentives to executives and other employees of MacDermid.  
The purpose of awarding equity incentives under the Plan is to enable 
MacDermid to attract, retain and motivate its employees to exert their 
best efforts to enhance shareholder value by giving them the ability to 
participate in the long-term growth of MacDermid.  The Committee 
generally considers the same factors in establishing the amounts of 
equity awards for MacDermid's executive officers as those listed above.  
The amounts of the awards are based upon the relative position of each 
executive officer within MacDermid and individual performance 
independent of the terms and amount of awards previously granted.

     Equity incentives awarded under the Plan are in the form of options 
to purchase a specified number of restricted shares of MacDermid Common 
Stock at an exercise price equal to 66.6% of the market price of the Common 
Stock on the date of award.  The options are exercisable only during the 
four-year period beginning on the date of award.  The shares of Common Stock 
acquired upon any exercise are treated as restricted stock for a period of 
four years commencing on the date of exercise.  Such shares may not be sold 
during such period (other than to MacDermid at the exercise price) and must 
be resold to MacDermid at the exercise price if the Plan participant's 
employment with MacDermid is terminated during such period, except in the 
case of death, retirement, permanent disability or involuntary termination 
without cause.  Such restrictions may, however, be waived by the Committee 
in its discretion from time to time.  The Committee believes that the Plan 
allows executive officers to participate in the enhancement of shareholder 
value but only after requiring them to share in the risk of share ownership 
by holding restricted stock for a period of four years.

CHIEF EXECUTIVE OFFICER COMPENSATION

The base annual salary and incentive bonus for Daniel H. Leever, MacDermid's 
Chief Executive Officer, were determined utilizing the methods and factors 
discussed above.  Mr. Leever's base annual salary was set at $275,000 in 
Fiscal Year 1995 based upon the foregoing factors and additional 
consideration including the growth of MacDermid's earnings to record levels 
and the Committee's appraisal of the effectiveness of programs instituted 
by Mr. Leever.  Mr. Leever received a bonus for the fiscal year ended March 
31, 1995 based on the stated bonus factors, each of which exceeded the 
minimum requirements for payment of a bonus, and adjusted to recognize 
programs implemented to improve the Corporation's capital structure, which, 
in the opinion of the Committee, will benefit the shareholders.  MacDermid's 
performance during the fiscal year ended March 31, 1995 placed MacDermid 
solidly in the upper range of the Comparator Group.  Approximately one-half 
of the incentive bonus was paid with respect to the EPS change with the 
balance attributable to the ROS and the ROE. During the fiscal year, Mr. 
Leever received the award of an option to purchase 25,000 shares of Common 
Stock.  The size of the award was equal to the award that Mr. Leever 
received in fiscal 1994.  In determining the size of the award, the 
Committee considered the likely effect upon shareholder value of the 
success of the programs proposed and embarked upon by Mr. Leever.

     Respectfully submitted by,

                        THE COMPENSATION COMMITTEE
                         Thomas W. Smith, Chairman
                             Donald G. Ogilvie 
                              James E. Smith
                          Walter F. Torrance, Jr.
                            Robert F. Weltzien
                             Francis M. White












































<PAGE>
<TABLE>
                         SUMMARY COMPENSATION TABLE

The following Summary Compensation Table summarizes annual, long-term and 
other compensation paid by MacDermid and its subsidiaries for each of its 
three fiscal years ended March 31, 1995 to MacDermid's Chief Executive 
Officer and four other most highly compensated executive officers.
<CAPTION>
                                                       Long-Term
                                                      Compensation
                           Annual Compensation          Awards
                           -------------------   -----------------------
                                                 Securities
                                                 underlying   All other
Name and                    Salary     Bonus      options   compensation
principal position   Year  ($) <F1>   ($) <F5>       (#)        ($) <F2>
- ------------------------------------------------------------------------
<S>                  <C>    <C>       <C>         <C>           <C>
Daniel H. Leever     1995   287,000   481,250     25,000         35,268
President and        1994   260,724   125,000     25,000         17,752
Chief Executive      1993   226,600   125,000     25,000         15,854
Officer

Charles T. Cobb <F3> 1995   123,732   150,000      8,000        113,786
Vice President       1994    61,047     4,900      5,000         12,879
                     1993       -         -          -              -

Terrence C. Copeland 1995   124,500   180,000      5,000         24,301
Vice President       1994   119,492    30,000      2,000         21,016
                     1993   113,300    43,449      5,000          8,728

Michael A. Pfaff     1995   126,750   180,000     10,000         20,273
Vice President       1994   109,969   105,000      5,000         14,480
                     1993   103,393    73,736      5,000         10,809

Charles D. Rice <F4> 1995   147,676   209,375     15,000         24,354
Vice President       1994   140,180    50,000      5,000         22,994
Chief Financial      1993   120,345    46,469      5,000         18,114
Officer and 
Treasurer

<FN>

<F1>  Salary figures include certain amounts which, previous to 1992, 
would have been included in MacDermid's contribution to the Profit 
Sharing Plan.  Employees generally have the right to contribute this 
amount to the Profit Sharing Plan under 401(k) rules.  However, due to 
limitations imposed by Internal Revenue Service Rules, certain executive 
officers are prevented from making such a contribution and receive the 
amount as additional cash compensation.

<F2>  Amounts listed for 1995 include payments by MacDermid for premiums 
for split dollar life insurance in the amounts of $4,384, $27,984, 
$5,984 and $9,679 on behalf of, respectively, Messrs. Leever, Cobb, 
Copeland, Pfaff and Rice; contributions to the E.S.O.P. in the amounts 
of $3,110, $3,500, $2,250 and $3,583 on behalf of, respectively, Messrs. 
Cobb, Copeland, Pfaff and Rice; moving expense reimbursement in the 
amount of $72,351 on behalf of Mr. Cobb; contributions to the Profit 
Sharing Plan in the amounts of $29,792, $9,265, $11,172, $11,172 and 
$14,151 on behalf of, respectively, Messrs. Leever, Cobb, Copeland, 
Pfaff and Rice; and premiums for term life insurance in the amounts of 
$1,092, $1,076, $1,416, $1,541 and $524 on behalf of, respectively, 
Messrs. Leever, Cobb, Copeland, Pfaff and Rice.
<F3>  Annual compensation for Mr. Cobb is shown only for the periods 
following his appointment as executive officer.

<F4>  Mr. Rice resigned as an executive officer of MacDermid effective 
April 15, 1995.

<F5>  Amounts listed for 1995 include a portion which has not been paid 
but which may be paid in restricted stock, subject to approval of the 
MacDermid,Incorporated 1995 Equity Incentive Plan by the Shareholders, 
and subject to the discretion of the Compensation Committee.

</TABLE>
































<PAGE>
<TABLE>




                           OPTION GRANTS IN LAST FISCAL YEAR

     The following table provides information with respect to stock options granted to the 
Chief Executive Officer and the named executive officers during the fiscal year ended 
March 31, 1995.

                                            Individual Grants
__________________________________________________________________________________________
<CAPTION>
                                                                                    Potential realizable value
                                 Percent                                            value at assumed annual 
                    Number of    of total                                           rates of stock price 
                    securities   options                                            appreciation for option term <F2>
                    underlying   granted to   Exercise  Market                     ----------------------------------
                    options      employees    or base   price
                    granted      in fiscal    price     on Date       Expiration 
Name                (#) <F1>     year         ($/Sh)    of Grant      date          0%($)        5%($)      10%($)
- ---------------------------------------------------------------------------------------------------------------------
<S>                 <C>          <C>         <C>        <C>            <C>         <C>         <C>         <C>   
Daniel H. Leever    25,000       25.9%       $16.1505   $24.44         4/18/98     $202,488    $491,945    $895,788

Charles T. Cobb      8,000        8.3%       $16.1505   $24.44         4/18/98     $ 64,796    $157,422    $286,652

Terrence C.          5,000        5.2%       $16.1505   $24.44         4/18/98     $ 40,498    $ 98,389    $179,158
Copeland

Michael A. Pfaff    10,000       10.4%       $16.1505   $24.44         4/18/98     $ 80,995    $196,778    $358,315

Charles D. Rice     15,000       15.5%       $16.1505   $24.44         4/18/98     $121,493    $245,167    $537,473

<FN>

<F1>  Shares of Common Stock acquired upon exercise of an option are 
treated as restricted stock for a period of four years commencing on the 
date of exercise.  Such shares may not be sold during such period (other 
than to MacDermid at the exercise price) and must be resold to MacDermid 
at the exercise price if the participant's employment with MacDermid is 
terminated during such period, except in the case of death, retirement, 
permanent disability or involuntary termination without cause.  Such 
restrictions may, however, be waived by the Compensation Committee in 
its discretion from time to time.

<F2>  Amounts are based upon an actual option term together with a 
restricted period totaling eight years.  At the end of eight years, the total 
value of the 2,742,533 shares owned as of March 31, 1995 by the shareholders 
of MacDermid at 5% and 10% compounding from the market price on the date of 
grant would be approximately $35.83 and $51.98 per share or an aggregate value 
for all shares of $98,265,000 and $142,557,000, respectively.
</TABLE>
<PAGE>
<TABLE>


               AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
                      AND FISCAL YEAR-END OPTION VALUES

     The following table provides information with respect to the aggregate 
number of unexercised options held on such date by the Chief Executive Officer 
and the named executive officers as of March 31, 1995.
<CAPTION>

                                            Number of              Value of
                 Shares                     Securities underlying  unexercised
                 acquired                   unexercised            in-the-money
                 on             Value       options at             options at
                 exercise       realized    FY-end (#)  <F2>        FY-end ($)
Name                 #           $ <F1>     Exercisable/           Exercisable
                                            Unexercisable            <F2><F3>

- -------------------------------------------------------------------------------
<S>                <C>        <C>             <C>                   <C>
Daniel H. Leever    7,500     $ 71,985        92,500                $2,443,203
Charles T. Cobb                               13,000                $  344,881
Terrence C.Copeland                           16,000                $  424,764
Michael A. Pfaff    2,050     $ 50,938        21,268                $  559,615
Charles D. Rice    10,000     $191,830        20,000                $  532,828

<FN>

<F1>  Value is determined as the spread between the exercise price
      and the market price on the date of exercise.

<F2>  All options were exercisable on the date of grant and at March 31,
      1995.

<F3>  Calculated using a market value per share at March 31, 1995 of 
      $43.00 as reported by the Nasdaq Stock Market.

</TABLE>





                             EMPLOYEES PENSION PLAN

     The MacDermid Employees Pension Plan (the 'Pension Plan) is a qualified 
defined benefit plan.  Pension payments may be made under the Pension Plan 
upon normal retirement commencing when an executive reaches age 60 based 
upon credited years of service up to a maximum of 30 years.  Annual benefits 
are calculated on a single-life annuity basis and are subject to offsets for 
(i) amounts based on the value of the executive's interest in the Profit 
Sharing Plan as of March 31, 1976, if any, and (ii) 0.45% of the lesser of 
covered compensation or final average compensation, as defined by the 
Internal Revenue Service Code (the "Code") Section 401(1), multiplied by 
the years of service.

     Under the MacDermid, Incorporated Supplemental Executive Retirement 
Plan (the "Supplemental Plan"), executive officers are entitled to the 
difference between the benefits actually paid to them under the Pension 
Plan and the benefits which they would have received under the Pension 
Plan were it not for certain restrictions imposed under the Code relating 
to the amount of benefits payable under the Pension Plan and the amount of 
annual compensation which may be taken into account in determining benefits 
under the Pension Plan.

     Assuming that there are no changes in the Pension Plan and that 
participants historically have had earnings at least equal to the maximum 
Social Security wage base in each year of employment with MacDermid, the 
following table illustrates the estimated annual benefit payable for life 
under the Pension Plan and the Supplemental Plan to an employee retiring 
at age 60 on March 31, 1995 with maximum service under the Plan of up to 
30 years.  These benefits neither reflect an offset for the participant's 
March 31, 1976 interest in the Profit Sharing Plan nor do they recognize 
a Social Security supplement which is payable under the Pension Plan until 
the employee reaches age 65.

<TABLE>
               ESTIMATED ANNUAL PENSION PAYABLE AT NORMAL RETIREMENT
                        BASED ON YEARS OF SERVICE INDICATED
<CAPTION>
Final Average
  Earnings        10 Years    15 Years    20 Years    25 Years   30 Years
- -------------------------------------------------------------------------
<S>               <C>         <C>         <C>         <C>        <C>
$150,000           21,049      31,573      42,097      52,621     63,146
$200,000           28,549      42,823      57,097      71,371     85,646
$250,000           36,048      54,073      72,097      90,121    108,145
$300,000           43,548      65,323      87,097     108,871    130,645
$350,000           51,048      76,573     102,097     127,621    153,145
$400,000           58,548      87,823     117,097     146,371    175,645
$450,000           66,048      99,073     132,097     165,121    198,145
$500,000           73,548     110,323     147,097     183,871    220,645
$600,000           88,548     132,823     177,097     221,371    265,645
$700,000          103,548     155,323     207,097     258,871    310,645
$800,000          118,548     177,823     237,097     296,371    355,645
</TABLE>

     Covered compensation under the Pension Plan includes an employee's 
annual salary and bonus, which, for the Chief Executive Officer and four 
other named executive officers, is set forth in the Summary Compensation 
Table.  Messrs. Leever, Cobb, Copeland, Pfaff, and Rice have 14, 20, 5, 
13, and 5 years of credited service, respectively, under the Pension Plan.





<PAGE>
                           COMPARATIVE STOCK PERFORMANCE


     The following graph and chart compare, during the five-year period 
commencing March 31, 1990 (at the market close) and ending March 31, 1995, 
the annual change in the cumulative total return on MacDermid's Common 
Stock with the Nasdaq Stock Market (U.S. & Foreign) and the Media General 
Specialty Chemicals Stock indices, assuming the investment of $100 on March 
31, 1990 (at the market close) and the reinvestment of any dividends.


                       FIVE YEAR CUMULATIVE TOTAL RETURN


                                  (Graph)


     (The graph provided here has three data lines.  Each line provides a 
representation of the cumulative total return achieved on MacDermid Common 
Stock, the Nasdaq Stock Market (U.S. and Foreign) and the Media General 
Specialty Chemicals Stock indices, respectively.  The three lines each begin 
at $100 and then diverge, connecting each of their respective five other 
data points.  The lines for the Nasdaq Stock Market and for Specialty 
Chemicals are similar and show fairly even growth from 1990 to 1995.  
MacDermid's data line generally trails Nasdaq and Specialty Chemicals 
through 1994 and, in 1995, increases to well above the comparator indices 
at the end of 1995.)

     Past share performance should not be viewed as necessarily indicative of 
future performance.
<TABLE>
<CAPTION>
Graph Dollar Values  1990     1991      1992      1993      1994     1995
- -------------------------------------------------------------------------
<S>                   <C>      <C>       <C>       <C>       <C>      <C>
MacDermid, Inc.       100      129       136       149       147      247

Nasdaq                100      114       145       166       181      198

Specialty Chemicals   100      122       150       155       167      173
</TABLE>












<PAGE>
<TABLE>

            SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
                           AND OF MANAGEMENT

     The following table sets forth information as of June 1, 1995, with
respect to ownership of Common Stock by any person known to MacDermid to be 
a beneficial owner of more than 5% of its Common Stock, by MacDermid's 
five most highly compensated executive officers and by all directors and 
officers of MacDermid as a group.  Unless otherwise noted, each person 
has sole voting and disposition power with respect to such person's 
shares.  The total of shares of Common Stock beneficially owned by the 
executive officers includes the right to acquire ownership through 
exercise of stock options.
- ---------------------------------------------------------------------------
<CAPTION>
                                        Number of Shares         Percent
     Beneficial Owner                   Beneficially Owned       of Class
- ---------------------------------------------------------------------------
<S>                                        <C>                    <C>
     FIVE PERCENT BENEFICIAL OWNERS

     Harold Leever                         207,035 <F1>            7.48
     366 Guilds Hollow Road
     Bethlehem, Connecticut 06751

     MacDermid Employees Profit Sharing,   669,169 <F2>           24.18
     Pension and Stock Ownership Plans
     245 Freight Street
     Waterbury, Connecticut  06702

     Thomas W. Smith and                   211,460 <F1>            7.64%
     Prescott Investors, Inc.
     323 Railroad Avenue
     Greenwich, Connecticut 06830

     Bank of Boston Corporation            264,196 <F3>            9.55%
     100 Federal Street
     Boston, Massachusetts 02110

     Lazard Freres & Co.                   157,300 <F4>            5.68%
     One Rockefeller Plaza
     New York, N.Y. 10020

     Vanguard/Primecap Fund, Inc.          189,000 <F5>            6.83%
     P.O. Box 2600
     Valley Forge, PA 19482

     NAMED EXECUTIVE OFFICERS

     Daniel H. Leever                      124,803<F1> <F6> <F7>   4.38
     Charles T. Cobb                        13,295<F6>               *
     Terrence C. Copeland                   18,833<F6>               *
     Michael A. Pfaff                       32,456<F6> <F7>        1.16
     Charles D. Rice                        38,800<F6>             1.40
     All Directors and Officers            773,846(6)             26.30
     as a group (19 persons)

<FN>

*  Less than 1% of shares outstanding

<F1>  Additional explanation of the shares beneficially owned by the 
Directors is provided in the footnotes under Election of Directors.

<F2>  463,566 shares in the MacDermid Employees Profit Sharing Plan 
and 161,908 shares in the MacDermid, Incorporated Employee Stock 
Ownership Plan are beneficially owned by the Trustee of the plans, 
Shawmut Bank, N.A., One Federal Street, Boston, MA 02211, and 43,695 
shares in the MacDermid, Incorporated Employees Pension Plan are 
beneficially owned by the Trustee of the plan, Investors Bank & Trust 
Company, 24 Federal Street, Boston, MA 02110.  Under the terms of the 
Profit Sharing Plan and the ESOP, participants have the right to vote 
the shares credited to their accounts; however, the Trustee may, in its 
discretion, vote any shares (including unallocated shares) not voted by 
the participants.  The trustee of the Pension Plan may vote all the 
MacDermid shares beneficially owned thereunder.

<F3>  The information for Bank of Boston Corporation ("BOB") is taken 
from its Schedule 13G dated February 13, 1995.  Through its subsidiary, 
Bank of Boston Connecticut, BOB has sole voting power with respect to 
264,196 shares, shared voting power with respect to no shares, sole 
dispositive power with respect to 89,190 shares and shared dispositive 
power with respect to 174,806 shares.  150,275 of the shares held by BOB 
are also beneficially owned by Mr. Harold Leever.  See footnote (1) under 
Election of Directors. 

<F4>  The information for Lazard Freres & Co. ("Lazard") is taken 
from its schedule 13G dated February 14, 1995.

<F5>  The information for Vanguard Primecap Fund, Inc. ("Primecap") 
is taken from its Schedule 13G dated February 10, 1995.

<F6>  The beneficial owners of these shares generally have sole voting and 
investment power.  Includes 124,803; 13,295; 18,833; 32,456 and 30,800 
shares of Common Stock held by Messrs. Leever, Cobb, Copeland, Pfaff and 
Rice, respectively, and 87,902 shares of Common Stock beneficially owned 
by 13 officers as a group in MacDermid's Profit Sharing and ESOP Plans.  
Also includes 80,000, 13,000, 16,000 and 21,268 shares of Common Stock 
which may be acquired upon exercise of options granted to Messrs. Leever, 
Cobb, Copeland, and Pfaff, respectively, and 175,268 shares of Common Stock 
in the aggregate which may be acquired upon exercise of options granted to 
10 officers as a group through MacDermid's Special Stock Purchase Plan.

<F7>  Includes 20,000 and 2,732 shares of Common Stock for Messrs. 
Leever and Pfaff, respectively, which are subject to restrictions on 
transfer under the Special Stock Purchase Plan.
</TABLE>
<PAGE>

                    INTEREST OF MANAGEMENT AND OTHERS
             IN CERTAIN TRANSACTIONS AND FAMILY RELATIONSHIPS

     Harold Leever is the Chairman, Director, and a nominee for Director 
of MacDermid.  Mr. Leever's son, Daniel H. Leever is President, Chief 
Executive Officer, a Director and a nominee for Director of MacDermid. 


                   ADDITIONAL INFORMATION RELATING TO
                  THE BOARD OF DIRECTORS AND COMMITTEES

     The Board of Directors held a total of six regular meetings during 
the 1995 fiscal year.  Each of the eight members of the Board of 
Directors attended 75% or more of the aggregate number of meetings of the 
Board and the committees of which they are members.  The Board has Audit, 
Compensation, Executive and Nominating Committees.

     The Audit Committee recommends independent auditors, reviews the 
scope of the audit examination and the independence of the auditors, 
reviews and approves non-audit services provided by the auditors, reviews 
findings and recommendations of the auditors and management's response 
thereto and reviews MacDermid's internal audit function.  The Committee 
met three (3) times during the 1995 fiscal year.  Members of the 
Committee are:  Thomas W. Smith, Chairman, Donald G. Ogilvie, James C. 
Smith, and retiring Directors, Walter F. Torrance, Jr., Robert F. 
Weltzien and Francis M. White.

     The Compensation Committee reviews and makes recommendations to 
the Board with respect to officer compensation and administers the 
MacDermid, Incorporated Special Stock Purchase Plan, determining the 
persons to whom equity incentives are to be granted, the number of shares 
to be granted and the manner in which the exercise price shall be 
payable.  The Committee, which met four (4) times during the 1995 fiscal 
year, includes Mr. Thomas W. Smith, Chairman, Donald G. Ogilvie, James C. 
Smith and retiring Directors, Walter F. Torrance, Jr., Robert F. Weltzien 
and Francis M. White.

     The Executive Committee may exercise, subject to limitations 
prescribed by law, those powers assigned to it by the Board of Directors.  
The Committee, which did not meet during the 1995 fiscal year, includes 
Harold Leever, Chairman; Daniel H. Leever, Donald G. Ogilvie, Thomas W. 
Smith, James C. Smith and retiring Directors, Walter F. Torrance, Jr., 
Robert F. Weltzien and Francis M. White.

     The Nominating Committee reviews and makes recommendations to the 
Board with regard to director nominees.  Any shareholder wishing to 
recommend a nominee to the Board should do so in writing addressed to 
John L. Cordani, Corporate Secretary, MacDermid, Incorporated, 245 
Freight Street, Waterbury, Connecticut 06702-0671.  The Committee, which 
met once during the 1995 fiscal year, includes Harold Leever, Chairman; 
Daniel H. Leever; Donald G. Ogilvie, Thomas W. Smith, James C. Smith and 
retiring Directors, Walter F. Torrance, Jr., Robert F. Weltzien and 
Francis M. White.

     Directors who are employees of MacDermid receive no compensation in 
addition to their salaries and benefits received as employees.  Directors 
who are not employees are paid $500 for each meeting of the Board 
attended, an additional $500 for each meeting of the Board exceeding four 
hours duration, $150 for each committee meeting attended not coincident 
with a meeting of the Board, a quarterly cash retainer of $750, and an 
annual retainer of $2,000 payable in shares of MacDermid Common Stock.  
MacDermid provides up to $50,000 group term life insurance for each 
outside director for which it paid a total of $635 in premiums during the 
1995 fiscal year.


                             SECTION 16 COMPLIANCE

     Mr. James C. Smith, a Director and current nominee, filed his Form  3, 
with respect to his election as a Director July 22, 1994, on August 3, 1994.






                                   ITEM 2

                           Proposal To Approve
          The MacDermid, Incorporated 1995 Equity Incentive Plan


     On May 15, 1995, the Board of Directors adopted, subject to approval 
by the shareholders, the MacDermid, Incorporated 1995 Equity Incentive 
Plan (the "Plan"), which provides for the grant to employees of MacDermid 
and its subsidiaries of restricted stock under the terms and conditions of 
the Plan.

The Board believes that it is advisable to adopt the Plan because it will 
enable MacDermid and its subsidiary corporations to grant certain of 
their employees the means to acquire a proprietary interest in MacDermid, 
thereby providing additional financial incentives for such employees to 
contribute to MacDermid's growth and profitability.  Further, the Board 
believes that the availability of such incentives will be a factor in 
attracting and retaining those highly competent individuals upon whose 
judgment, initiative and leadership MacDermid's continuing success in 
large measure depends.  Therefore, the Board of Directors recommends that 
the shareholders approve the Plan.

     The principal provisions of the Plan are summarized below.  This 
summary is qualified in its entirety by reference to the Plan, a copy of 
which is attached hereto as Exhibit A.

     The Plan is administered by a committee of not fewer than two 
members of the Board of Directors (the "Committee"), each of whom must be 
a "disinterested person" within the meaning of Rule 16b-3(c) under the 
Securities Exchange Act of 1934, as amended ("Rule 16b-3") and an 
"outside director" within the meaning of section 162(m)(4)(c)(i) of the 
Internal Revenue Code (the "Code").  The Committee may adopt such rules 
and regulations as it may deem desirable for administration of the Plan.

     Under the Plan, restricted shares may be granted for an aggregate, 
subject to certain adjustments, of up to 50,000 shares of Common Stock.  
Such shares may be treasury shares or may be authorized and unissued 
shares.  Not more than 25,000 restricted shares may be issued under the 
Plan in any one year.  On June 1, 1995, the closing price of a share of 
MacDermid stock on the Nasdaq National Market System was 44-3/4.  A 
participant who is awarded restricted stock will have no rights with 
respect to such award unless the participant accepts the award by written 
instrument delivered to the Company accompanied by payment in full of the 
specified purchase price.  Payment may be made in cash, certified or 
cashiers check or at the discretion of the Committee, by delivering 
shares of Common Stock having a fair market value not less than the 
amount for which payment is being made.  Subject to certain exceptions, 
all shares of restricted stock issued under the Plan must be held and 
cannot be sold or otherwise transferred by the participant (except to 
MacDermid for the price paid therefor) for a period of four (4) years 
from the date of the award.  In its sole discretion, the Committee may 
waive the restrictions against transfer applicable to the shares prior to 
the expiration of the four (4) year period.

     Under the Plan the Committee will select the appropriate individuals 
who will participate.  Subject to the provisions of the Plan the 
Committee will then determine the size of the award of restricted stock 
("Restricted Stock"), the conditions under which the award will be made, 
the purchase price to be paid, and the restrictions to be placed upon the 
shares.  In the case of a participant who also participates in a 
MacDermid annual bonus plan, an award, if any, will be comprised of 
Restricted Stock having a fair market value equal to twenty (20%) of the 
annual bonus payout awarded to the participant under the applicable bonus 
plan and will be made in lieu of the allocable bonus amount.  The 
Committee in its discretion may also award such a participant an 
additional number of shares as long-term compensation in any multiple or 
fraction of the number of shares awarded in lieu of the allocable bonus 
payout.  The total annual award to any participant in any one year may 
not exceed an amount equal to that participant's annual bonus payout for 
such year.  A participant will have all the rights of a stockholder with 
respect to the Restricted Stock awarded to him or her including voting 
and dividend rights, subject to any applicable restrictions on transfer 
and MacDermid repurchase rights, and subject to any other conditions 
contained in the award.

     If a participant's employment by MacDermid is terminated for any 
reason other than death, retirement in accordance with MacDermid"s 
qualified pension plan at or after attainment of age sixty (60), 
permanent disability or involuntary termination without cause while the 
participant holds shares which are subject to restrictions on transfer 
imposed by the Plan, the participant is required, at MacDermid's option, 
to sell such shares to MacDermid for the price he or she paid for the 
shares.  However, if a participant's employment is terminated due to 
death or permanent disability any restrictions on the transfer of shares 
held by the participant pursuant to the Plan will lapse and such shares 
may be freely transferred.

     If a participant's employment is terminated by retirement in 
accordance with MacDermid's qualified pension plan at or after attainment 
of age sixty (60) while the participant holds shares which are subject to 
restrictions on transfer imposed by the Plan, the participant will be 
required to sell such shares to MacDermid for the price paid therefor if 
the Committee determines that the participant has engaged in misconduct, 
or if the participant competed with MacDermid within the restriction period.  
If the employment of a holder of shares of Restricted Stock is terminated 
due to involuntary termination without cause, while the shares are subject 
to restrictions, the restrictions on such shares shall be deemed to have 
lapsed in annual installments of twenty-five (25) percent on the first 
anniversary of the date of award of such shares and twenty-five (25) percent 
on each of the next three anniversaries of such date.  Provision is made in 
the Plan for waiver of restrictions, at the discretion of the Committee.

     In the event that MacDermid's outstanding shares of Common Stock are 
increased or decreased as the result of a stock dividend, stock split, 
recapitalization or other similar event, the number of shares available 
for issuance under the Plan may be adjusted to the extent the Committee 
deems appropriate, with the approval of counsel, to preserve the rights 
of the participants.

     In addition, if MacDermid reclassifies or exchanges outstanding 
shares of Common Stock, consolidates or merges with or into another 
corporation or otherwise recapitalizes or reorganizes (other than with 
a subsidiary controlled by MacDermid), or sells or conveys to another 
corporation all or substantially all of MacDermid's assets (each a 
"Reorganization"), a Plan participant will have the right upon receipt 
of shares pursuant to an award to acquire the same kind and amount of 
securities and property which the participant would have been able to 
acquire if the participant had received such shares immediately before 
the Reorganization.  In addition, the Committee will have the right in 
connection with any Reorganization to terminate all outstanding awards 
and/or to remove restrictions from some or all outstanding shares of 
restricted stock.  

     If any person or entity owns or acquires, directly or indirectly, 
shares of the capital stock of MacDermid entitled to cast 25% or more of 
the votes to be cast generally in an election of directors (other than 
any such shares owned or acquired by any qualified employee benefit plan 
maintained by MacDermid), all restrictions imposed on any shares of 
Common Stock issued pursuant to the Plan will immediately lapse unless 
all members of the Board, who were members before such event and who 
comprise a majority of the Board of Directors, determine otherwise by 
unanimous vote.

     The Board of Directors may amend, suspend, or terminate the Plan 
except that no action may be taken which impairs participants' rights 
under outstanding awards without their consent and no amendment may be 
made without shareholder approval where such approval is required under 
Rule 16b-3 under the Securities and Exchange Act of 1934.  The Committee 
may substitute new awards for awards previously granted to participants.

     A recipient of Restricted Stock generally will be subject to tax at 
ordinary income rates on the fair market value of the stock at the time 
the stock is no longer subject to forfeiture, less any amount paid for 
the stock.  However, a recipient who makes an election under Section 
83(b) of the Code within 30 days of the date of issuance of the 
Restricted Stock will realize ordinary income on the date of issuance 
equal to the fair market value of the shares of Restricted Stock at that 
time (measured as if the shares were unrestricted and could be sold 
immediately), less any amount paid for the stock.  If the election is 
made, no taxable income will be recognized when the shares subject to the 
election are no longer subject to forfeiture.  If the shares subject to 
the election are forfeited, the recipient will not be entitled to any 
deduction, refund or loss for tax purposes with respect to amounts 
previously included in income.  Subject to the limitations of Section 
162(m) of the Code, MacDermid, in general, will be entitled to a 
deduction equal to the amount of income recognized by the recipient in 
respect of the transfer of the shares of Restricted Stock.  The holding 
period to determine whether the recipient has long-term or short-term 
capital gain or loss upon sale of the shares after the forfeiture period 
has expired begins when the restriction period expires (or upon earlier 
issuance of the shares, if the recipient elected immediate recognition of 
income under Section 83(b) of the Code.)

     The choice of individuals who will participate in the Plan is 
subject to the discretion of the Committee.  In addition, any award made 
is subject to acceptance by the participant in accordance with its terms.  
As a result, it is not possible to indicate at this time the specific 
awards which may be received by any individual participant or groups of 
participants under the Plan.

     Under the terms of the Plan, as adopted by the Board of Directors, 
and as provided in the By-Laws of MacDermid, approval requires the 
affirmative vote of the holders of a majority of the Common Stock 
represented at the Meeting.

     The Board of Directors recommends a vote "for" adoption of the 
MacDermid, Incorporated 1995 Equity Incentive Plan (Item 2).

















<PAGE>
                     INDEPENDENT ACCOUNTANTS

     The independent public accountants for MacDermid for fiscal year 
1995 were KPMG Peat Marwick LLP ("KPMG"), which firm has been selected to 
be MacDermid's auditors for fiscal year 1996 by the Board of Directors.  
At the Meeting, a representative of KPMG will have the opportunity to 
make a statement if he or she wishes to do so and will be available to 
answer any appropriate questions that may be asked by shareholders.


          SHAREHOLDER PROPOSALS FOR 1995 ANNUAL MEETING

     Shareholder proposals for inclusion in the proxy statement relating 
to the 1996 annual meeting must comply in all respects with the rules and 
regulations of the Securities and Exchange Commission and be received at 
MacDermid's principal executive offices at 245 Freight Street, Waterbury, 
Connecticut 06702-0671 no later than February 27, 1996.  Such proposals 
should be addressed to the attention of John L. Cordani, Corporate 
Secretary.


                          ANNUAL REPORT

     This Proxy Statement has been preceded by or is accompanied with the 
Annual Report for the fiscal year ended March 31, 1995.  Shareholders are 
referred to such report for financial and other information about the
activities of the Corporation, but such report is not to be deemed a
part of the proxy soliciting material.


                              MISCELLANEOUS

     The Board of Directors knows of no matters other than those referenced 
in the Notice of Annual Meeting which are to be brought before the Meeting.  
However, if any other matters are properly presented, it is the intention 
of the persons named in the Proxy to vote the Proxy in accordance with their 
best judgment.

     It is important that Proxies be returned prior to the Meeting.  
Shareholders are urged to sign and date the enclosed Proxy and promptly 
return it in the enclosed envelope.


June 26, 1995                           JOHN L. CORDANI
                                        Corporate Secretary



     MacDermid, Incorporated will provide without charge, to any 
shareholder, upon written request, a copy of its Annual Report on Form 
10-K to the Securities and Exchange Commission for the fiscal year ended 
March 31, 1995.  Such request should be directed to John L. Cordani, 
Corporate Secretary, MacDermid, Incorporated, 245 Freight Street, 
Waterbury, Connecticut  06702-0671.

<PAGE>
                                                                Exhibit A
                    MACDERMID, INCORPORATED
                   1995 EQUITY INCENTIVE PLAN

                    Effective May 15, 1995

      1. PURPOSES.  The purposes of the MacDermid, Incorporated 1995 
Equity Incentive Plan (the "Plan") are (a) to enable MacDermid, 
Incorporated and its subsidiary corporations (hereinafter referred to, 
unless the context otherwise requires, as the "Company") to provide to 
its employees the means to acquire a proprietary interest in the Company, 
in order that such persons will have additional financial incentives to 
contribute to the Company's growth and profitability, and (b) to enhance 
the ability of the Company to attract and retain individuals of outstanding 
ability upon whom the success of the Company will depend.  The Plan is 
intended to accomplish these goals by enabling the Company to grant awards 
("Awards") in the form of restricted stock, all as more fully described 
below.

     2. ADMINISTRATION.  The Plan shall be administered by a committee of 
not fewer than two members of the Board of Directors of the Company (the 
"Board").  Each member of the Committee shall be a "disinterested person" 
within the meaning of Rule 16b-3(c) under the Securities Exchange Act of 
1934, as amended (the "Act") and an "outside director" within the meaning 
of Section 162(m)(4)(C)(i) of the Internal Revenue Code of 1986, as 
amended (the "Code") and applicable Treasury regulations thereunder.  The 
Committee may adopt such rules and regulations as it may deem necessary 
or advisable for the administration of the Plan.  The Committee shall 
have no authority to take any action if the authority to take such action, 
or the taking of such action, would disqualify the Plan from the exemption 
provided by Rule 16b-3 under the Act or any successor provision.

     3. PARTICIPANTS.  All employees of the Company shall be eligible to 
receive Awards and thereby become participants in the Plan.  In granting 
Awards the Committee may include or exclude previous participants in the 
Plan as the Committee may determine.  Receipt of an Award shall in no way 
be deemed to constitute a consent to or promise of continued employment 
by the Company.

     4. SHARES SUBJECT TO THE PLAN.  Subject to adjustment as provided 
herein, an aggregate of up to 50,000 shares of the Common Stock, without 
par value per share (the "Common Stock"), shall be available for issuance 
under the Plan.  Such shares may be authorized and unissued shares or 
shares held in the Company's treasury.  If any Award in respect of shares 
of Common Stock is forfeited for any reason or settled in a manner that 
results in fewer shares of Common Stock outstanding than were initially 
awarded, including without limitation the surrender of shares of Common 
Stock in payment of any tax obligation on the Award, the shares of Common 
Stock subject to such Award or so surrendered, as the case may be, to the 
extent of such forfeiture or decrease, shall again be available for award 
under the Plan.


     5. GRANT OF AWARDS.

        (a)  Subject to the provisions of the Plan, the Committee may 
award shares of restricted stock to a participant under the Plan.  A 
restricted stock Award entitles the recipient to acquire, for a purchase 
price equal to or exceeding par value, shares of Common Stock subject to 
the restrictions described in Section 6 below ("Restricted Stock").  A 
maximum of 25,000 shares of Restricted Stock may be awarded by the 
Committee in any year.

        (b)  Subject to the provisions of the Plan, the Committee  shall 
determine the persons to whom Awards are to be granted, the size of the 
Award and all other terms and conditions of the Award, provided, however, 
that in the case of a Plan participant who is also then a participant in 
a Company annual bonus plan, any Award granted by the Committee to such 
participant shall be comprised of:

             (i)  That number of shares of Restricted Stock having a fair 
market value as of the date of the Award, as determined in good faith by 
the Committee, equal to twenty (20) percent of the annual bonus payout 
awarded to the participant under the applicable bonus plan (such Award 
to be in lieu of payment of the allocable bonus amount); plus

             (ii)  That additional number of shares, if any, which the 
Committee in its sole discretion determines is appropriate to award to 
the participant for long-term compensation and which is a fraction or 
multiple of the number of shares awarded to the participant under the 
immediately preceding clause (i);

provided, further, however, that in no event shall the fair market value 
of shares awarded to any participant under the preceding clauses (i) and 
(ii) exceed in any year one  hundred (100) percent of the annual bonus 
payout awarded to the participant under the applicable bonus plan.

     6. TERMS OF RESTRICTED STOCK.

        (a)  A participant who is granted a Restricted Stock Award will 
have no rights with respect to such Award unless the participant accepts 
the Award by written instrument delivered or mailed to the Company 
accompanied by payment in full of the specified purchase price, if any, 
of the shares covered by the Award.  Payment may be by certified or bank 
check or other instrument acceptable to the Committee.

        (b)  A participant who receives Restricted Stock will have all 
rights of a stockholder with respect to the Stock, including voting and 
dividend rights, subject to the restrictions described in this Section 6 
and any other conditions imposed by the Committee at the time of grant.  
Unless the Committee otherwise determines, certificates evidencing shares 
of Restricted Stock will remain in the possession of the Company until 
(i) such shares are free of all restrictions under the Plan and (ii) the 
participant provides for payment to (or withholding by) the Company of all 
amounts, if any, required under then applicable provisions of the Code and 
state and local tax laws to be withheld with respect to the issuance of 
such shares to the participant. 

        (c)  Except as otherwise specifically provided by the Plan, 
Restricted Stock may not be sold, assigned, transferred, pledged or 
otherwise encumbered or disposed of, except to the Company (if the 
Company agrees to purchase the shares) for an amount equal to the price 
paid for the shares, for a period of four (4) years from the date of 
issuance pursuant to an Award; provided, however, that the Committee in 
its sole discretion may determine from time to time for any reason to 
waive in whole or in part the restrictions applicable to any shares prior 
to the expiration of such four (4) year period.

        (d)  If the employment of a holder of shares of Restricted Stock 
is terminated for any reason other than death, retirement in accordance 
with the Company's qualified pension plan at or after attainment of age 
sixty (60),  permanent disability or involuntary termination without 
cause, while the shares are subject to the restrictions described in the 
immediately preceding paragraph, the holder shall be required to sell 
such shares to the Company for the price paid therefor by the holder, and 
all rights of the holder with respect to such shares shall be immediately 
canceled, unless the Company declines in writing to purchase the shares.

        (e)  If the employment of a holder of shares of Restricted Stock 
is terminated for retirement in accordance with the Company's qualified 
pension plan at or after attainment of age sixty (60), and the Committee, 
at any time while the shares are subject to the restrictions described in 
paragraph (c) above, determines that the holder, either before or after 
termination of the holder's employment by the Company,

             (i)  has committed an act of misconduct for which he or she 
could have been discharged for cause by the Company, or

             (ii)  has engaged, directly or indirectly, in competition 
with the Company, whether as an officer, employee, agent, proprietor or 
otherwise of, or by having any material investment or other material 
interest in, any business that involves in whole or in part any product 
or device similar to or competitive with any product or device sold by the 
Company during the employment of the holder or under active development by 
the Company at the time of the holder's cessation of employment, the holder 
shall be required to sell such shares to the Company for the price paid 
therefor by the holder, and all rights of the holder with respect to such 
shares shall be immediately canceled, unless the Company declines in writing 
to purchase the shares.

        (f)  If the employment of a holder of shares of Restricted Stock 
is terminated due to involuntary termination without cause, while the 
shares are subject to the restrictions described in paragraph (c) above, 
the restrictions on such shares shall be deemed to have lapsed in annual 
installments as follows:  twenty-five (25) percent on the first anniversary 
of the date of award of such shares and twenty-five (25) percent on each of 
the next three anniversaries of such date (reduced in the event of any 
resulting fraction to the next lowest whole number).

        (g)  If the employment of a holder of shares of Restricted Stock is 
terminated due to death or permanent disability, while the shares are subject 
to the restrictions described in paragraph (c) above, the restrictions on 
such shares shall lapse as of the date of such event, and the holder shall 
be free to dispose of the shares without further restriction.

        (h)  The restrictions imposed under this Section 6 shall apply 
as well to all shares or other securities issued in respect of shares in 
connection with any stock split, reverse stock split,  stock dividend, 
recapitalization, reclassification, spinoff, split-off, merger, 
consolidation or reorganization.  Any stock certificate issued in respect 
of shares awarded under the Plan shall be registered in the name of the 
participant, and shall bear an appropriate legend referring to the terms, 
conditions and restrictions applicable to such shares.

     7. CONDITIONS TO EFFECTIVENESS OF THE PLAN.  The Plan shall not 
become effective, and any Awards granted under the Plan shall not be 
effective, unless and until the Plan shall have been duly approved by the 
shareholders of the Company.

     8. AMENDMENT AND TERMINATION.  The Board by resolution at any time
may amend, suspend or terminate the Plan, provided that (a) no such 
action shall be taken which impairs the rights of any participant under 
any outstanding Award, without such participant's consent, and (b) no 
amendment shall be made without shareholder approval if such approval 
is necessary to comply with any applicable tax or regulatory requirement, 
including any requirements for exemptive relief under Section 16(b) of 
the Act, or any successor provision.

     9. EFFECT OF CHANGES IN COMMON STOCK.  If the Company shall 
combine, subdivide or reclassify the shares of Common Stock which have 
been or may be awarded under the Plan, or shall declare thereon any 
dividend payable in shares of Common Stock, or shall take any other 
action of a similar nature affecting the Common Stock, then the number 
and class of shares of stock as to which Awards may thereafter be granted 
(in the aggregate and to any participant) shall be appropriately adjusted 
and, in the case of each Award outstanding at the time of any such 
action, the number and class of shares subject to such Award shall 
likewise be appropriately adjusted, all to such extent as may be 
determined by the Committee in its sole discretion, with the approval of 
counsel, to be necessary to preserve unimpaired the rights of the 
participant.  Each and every such determination shall be conclusive and 
binding upon the participants.

     10. EFFECT OF REORGANIZATIONS.  In case of any one or more 
reclassifications, changes or exchanges of outstanding shares of Common 
Stock or other stock (other than as provided in Section 11), or 
consolidations of the Company with, or mergers of the Company into, other 
corporations, or other recapitalizations or reorganizations (other than 
consolidations with a subsidiary in which the Company is the continuing 
corporation and which do not result in any reclassifications, changes or 
exchanges of shares of the Company), or in case of any one or more sales 
or conveyances to any other corporation of the property of the Company as 
an entirety, or substantially as an entirety, any and all of which are 
hereinafter in this Section called "Reorganizations," a participant shall 
have the right, upon any subsequent receipt of shares pursuant to an Award, 
to acquire the same kind and amount of securities and property which such 
participant would then have if such participant had received such shares 
immediately before the first of any such Reorganizations and continued to 
hold all securities and property which came to such participant as a result 
of that and subsequent Reorganizations, less all securities and property 
surrendered or canceled pursuant to any of the same, the adjustment rights 
in Section 9 and this Section 10 being continuing and cumulative.

     Notwithstanding any provision of Section 6 or any foregoing 
provision of this Section 10 to the contrary, the Committee shall have 
the right in connection with any Reorganization, upon not less than 
thirty (30) days' written notice to the participants, to terminate all 
outstanding Awards.  In connection with such termination, the Committee 
in its discretion, prior to the effective date of the reorganization, may 
remove the restrictions from some or all outstanding shares of Restricted 
Stock.

     11. CHANGE IN CONTROL.  In the event that at any time after the 
effective date of the Plan the Company shall have a "Principal 
Stockholder," as hereinafter defined, then notwithstanding anything to 
the contrary contained herein, upon the date such event occurs, all 
restrictions imposed pursuant to Section 6 with respect to shares shall 
immediately lapse, unless the Board by unanimous vote of members who 
served as directors before such event and who constitute at least fifty-one 
(51) percent of the Board determines otherwise.

     For purposes of this Section 11, (a) the term "Principal 
Stockholder" means any corporation, person or other entity ("person") 
owning beneficially, directly or indirectly, shares of the capital stock 
of the Company entitled to cast twenty-five percent (25%) or more of the 
votes at the time entitled to be cast generally in the election of 
Directors by all of the outstanding shares of all classes of capital 
stock of the Company (other than any such shares held by any qualified 
employee benefit plan maintained by the Company), considered for purposes 
of this Section 11   as one class; (b) in determining such ownership, a 
person shall be deemed to be the beneficial owner of any shares of 
capital stock of the Company which are beneficially owned, directly or 
indirectly, by any other person (i) with which it or its "affiliate" or 
"associate," as hereinafter defined, has any agreement, arrangement or 
understanding for the purposes of acquiring, holding, voting or disposing 
of capital stock of the Company or (ii) which is its "affiliate" or 
"associate;" (c) a person shall be deemed to be an "affiliate" of, or 
affiliated with, a specified person if such person directly, or indirectly 
through one or more intermediaries, controls, or is controlled by, or is 
under common control with, the person specified; and (d) the term 
"associate" used to indicate a relationship with any person shall mean (A) 
any corporation or organization (other than the Company or any subsidiary 
of the Company) of which such person is an officer or partner or is, 
directly or indirectly, the beneficial owner of ten percent (10%) or more 
of any class of equity security, (B) any trust or other estate in which 
such person has a substantial beneficial interest or as to which such 
person serves as trustee or in a similar fiduciary capacity, and (C) any 
relative or spouse of such person, or any relative of such spouse, who has 
the same home as such person.

     12. GENERAL PROVISIONS.  

         (a)  Notwithstanding any other provision of the Plan, to the 
extent required to qualify for the exemption provided by Rule 16b-3 under 
the Act, and any successor provision, any Common Stock or other equity 
security offered under the Plan to a person subject to Section 16 of the 
Act may not be sold for at least six months after acquisition.

         (b)  Each Award under the Plan shall be evidenced by a writing 
delivered to the participant specifying the terms and conditions thereof 
and containing such other terms and conditions not inconsistent with the 
provisions of the Plan as the Committee considers necessary or advisable 
to achieve the purposes of the Plan or comply with applicable tax or 
regulatory laws and accounting principles.

         (c)  The terms of each Award need not be identical, and the 
Committee need not treat participants uniformly.  Except as otherwise 
provided by the Plan or a particular Award, any determination with 
respect to an Award may be made by the Committee at the time of award 
or at any time thereafter.

         (d)  No Award may be transferred other than by will or by the 
laws of descent and distribution.

         (e)  When a participant purchases Restricted Stock pursuant to 
an Award for a price equal to the par value of the Restricted Stock, the 
Committee in its discretion may determine that such price has been 
satisfied by past services rendered by the participant. 

     13. INTERPRETATION.  The interpretation and construction of any 
provision of the Plan and the adoption of rules and regulations for 
administering the Plan shall be made by the Committee.  Determinations 
made by the Committee with respect to any matter or provision contained 
in the Plan shall be final, conclusive and binding upon the Company and 
upon all participants, their heirs and legal representatives.  Any rule 
or regulation adopted by the Committee (whether under the authority of 
this Section or Section 2 above) shall remain in full force and effect 
unless and until altered, amended or repealed by the Committee.

















<PAGE>

                                                            Appendix A

                              FORM OF PROXY
                                 (Front)



PROXY                   MACDERMID, INCORPORATED                  PROXY

       This Proxy is Solicited on Behalf of the Board of Directors

   Annual Meeting of Shareholders -- July 20, 1995 at 3:30 P.M., E.D.T.
   At The Holiday Inn Waterbury, 63 Grand Street, Waterbury, Connecticut

     The undersigned hereby constitutes and appoints HAROLD LEEVER and 
DANIEL H. LEEVER, or either of them, with full power of substitution in 
each, attorneys and proxies to act on behalf of the undersigned at said 
meeting and at any adjournment thereof, with authority to vote on the 
following matters all shares of stock which the undersigned would be 
entitled to vote at said Meeting if personally present as directed on 
the reverse side hereof with respect to the items set forth in the 
accompanying Proxy Statement and in their discretion upon such other 
matters as may properly come before the Meeting.

   PLEASE MARK, DATE, SIGN AND RETURN THIS PROXY VOTING INSTRUCTION CARD
                        IN THE ENCLOSED ENVELOPE.

               (Continued and to be signed on reverse side.)
























<PAGE>

                                  (Reverse)


   PLEASE MARK VOTE IN OVAL IN THE FOLLOWING MANNER USING DARK INK ONLY.

A vote FOR items 1, 2 and 3 is recommended by the Board of Directors.
1. Election of Directors                
   Nominees: Harold Leever, Daniel H. Leever, 
   Donald G. Ogilvie, James C. Smith and
   Thomas W. Smith
               FOR WITHHOLD FOR ALL (Except Nominee(s) written below)
               [ ]    [ ]     [ ]   _________________________________

2. Approval of MacDermid, Incorporated 1995 Equity Incentive Plan
               FOR   AGAINST   ABSTAIN
               [ ]     [ ]       [ ]

3. In their discretion, upon any other matters as may properly come 
   before the meeting.
               AUTHORITY  AUTHORITY
               GRANTED     WITHHELD
                [ ]          [ ]

This proxy, when properly executed, will bevoted in the manner 
directed herein by the stockholder.  If no direction is made, 
this proxy will be voted FOR the above matters.

      Dated:________________________,1995
Signature(s)_____________________________
            _____________________________
       NOTE:  Please sign exactly as name appears hereon. 
       For joint accounts both owners should sign. When 
       signing as executor, administrator, attorney, 
       trustee, guardian, corporate officer, etc., please 
       give your full title.


[Space is provided for a mailing label containing the 
shareholder's name, address, account number, CUSIP 
number, sequence number and number of shares.]




                                                            EXHIBIT 13

PORTIONS OF MACDERMID'S 1995 ANNUAL REPORT TO STOCKHOLDERS.


Except for the pages and information expressly incorporated by 
reference, the financial and other information included in this Exhibit 
13 is provided solely for the information of the Securities and Exchange 
Commission and is not deemed "filed."

<PAGE>
<TABLE>
                              FINANCIAL HIGHLIGHTS

(In thousands, except share and per share data)
<CAPTION>
                                       1995         1994      % Change
                                   -----------------------------------
<S>                                <C>           <C>           <C>
Net Sales, North America           $  93,867     $  73,861        27
   Overseas                           88,233        76,165        16
                                   -----------------------------------
     Total Revenues                $ 182,100     $ 150,026        21
                                   ===================================
Net Earnings*                      $  11,142     $   7,771        43
   Return on Sales*                     6.1%          5.2%         -
   Return on Average Equity*           18.3%         11.7%         -

Net Cash Provided by Operations    $  20,733     $  15,766        32
Research and Development Expense   $   9,644     $   6,687        44
Capital Expenditures               $   3,990     $   7,526       (47)
Long-term Debt 
   (Includes Short-term Portion)   $  22,535     $   1,157     1,848
Average Shares Outstanding         3,141,855     3,567,875       (12)
Shareholders' Equity               $  53,654     $  68,169       (21)
Per Common Share
   Net Earnings*                       $3.55         $2.18        63
   Cash Dividends                      $0.60         $0.60         -
   Book Value                         $19.56        $19.11         2
</TABLE>
<TABLE>
                               GRAPHIC PRESENTATION
(Three horizontal bar graphs are provided here, proprietary net sales, 
net earnings and earnings per share.  Each graph depicts one facet of 
results of operations for the fiscal years 1991 through 1995.  The graph 
for proprietary net sales indicate a decline in sales in 1992, an 
increase in 1993, followed by a marginal increase in 1994 and a large 
increase in 1995.  The graphs for both net earnings and earnings per 
share indicate increases in each year since 1991 with a substantial 
increase in 1995.)
                                  GRAPH VALUES

(Amounts in thousands except per share data)
<CAPTION>
                         1991      1992      1993      1994       1995
                       ------------------------------------------------
<S>                    <C>       <C>       <C>       <C>       <C>
Proprietary net sales  $120,937  $115,595  $130,132  $130,601  $163,315

Net earnings           $  6,784  $  7,244  $  7,687  $  7,771  $ 11,142

Earnings per share        $1.90     $2.03     $2.16     $2.18     $3.55

</TABLE>

* Before the cumulative effect of accounting changes which resulted 
in one-time after tax charges of $371,000 ($0.12/share) in 1995 and 
$2,082,000 ($0.58/share) in 1994.  Fiscal 1995 indicates primary 
earnings per share.

<PAGE>
<TABLE>
                                      FIVE YEAR FINANCIAL REVIEW

(In thousands, except share and per share data)
<CAPTION>
OPERATING RESULTS                                1995        1994        1993       1992        1991
- -------------------------------------------------------------------------------------------------------
<S>                                          <C>        <C>           <C>         <C>         <C>  
Net Sales                                    $ 182,100  $ 150,026     $ 156,324   $ 144,984   $ 151,359
Net Earnings<F1>                             $  11,142  $   7,771     $   7,687   $   7,244   $   6,784
    Net Earnings Per Share <F1> <F2>             $3.55      $2.18         $2.16       $2.03       $1.90
    Return On Sales (%)<F1>                        6.1        5.2           4.9         5.0         4.5
    Return On Average Equity (%)<F1>              18.3       11.7          12.1        12.7        12.9

FINANCIAL POSITION AT YEAR END
- -------------------------------------------------------------------------------------------------------
Working Capital                              $  34,711  $  34,959     $  31,050   $  27,620   $  23,301
    Current Ratio                                  1.7        2.0           1.8         1.7         1.5
Capital Expenditures                         $   3,990  $   7,526<F3> $   4,594   $   4,453   $   3,198
Total Assets                                 $ 123,305  $ 105,867     $ 107,173   $ 101,214   $ 103,252
Long-Term Debt (Includes Short-Term Portion) $  22,642  $   1,157     $   2,684   $   2,812   $   4,199
    Percent of Total Capitalization               29.7        1.7          4.0         4.4         7.0

SHARE DATA
- -------------------------------------------------------------------------------------------------------
Shareholders' Equity                         $  53,654  $  68,169     $  65,181   $  61,050   $  55,848
    Per Share                                   $19.56     $19.11        $18.27      $17.12      $15.67
Cash Dividends Per Share                         $0.60      $0.60         $0.60       $0.60       $0.60
    Payout as Percent of Net Earnings <F1>        15.9       27.6          27.8        29.5        31.5
Shares Outstanding
    Average During Year                      3,141,855  3,567,875     3,565,371   3,565,000   3,565,000
    At Year End                              2,742,533  3,567,882     3,567,382   3,565,000   3,565,000
Stock Price          
    High                                       44 1/2     31            29 1/2      29          26 1/2
    Low                                        24         24 1/2        23 3/4      21          16 1/2
    Year End                                   43         26            27          28 1/8      24 1/2
<FN>
<F1> Before cumulative effect of accounting changes which resulted in one-time after tax charges of 
     $371,000 ($0.12/share) in 1995 and $2,082,000 ($0.58/share) in 1994.

<F2> For 1995 indicates primary earnings per share.  Fully diluted earnings per share were $3.50 for 
     1995, the first period during which the dilutive effect was large enough to report.

<F3> Includes cost attributable to a new Hong Kong warehouse and office facility and is not offset by 
     proceeds from disposal of the previous facilities which occurred in fiscal 1995 and 1994.
</TABLE>

<PAGE>
                          MESSAGE TO SHAREHOLDERS

   Fiscal 1995 was the third consecutive year of record earnings for 
MacDermid.

     Sales increased to $182.1 million from $150 million in 1994, up 
21%.  Earnings* increased to $11,142,000 from $7,771,000 in 1994, up 
43%.  Earnings per share* increased to $3.55 from $2.18 in 1994, up 
63%.  The significantly greater percentage increase in earnings per 
share was largely a result of our repurchase in August of 24% of our 
outstanding shares.

     MacDermid is an international specialty chemical company 
serving the metal finishing and electronics industries.  Our focus 
is to increase the per share intrinsic value of the business by the 
combination of careful cost control, internal growth and 
acquisitions.  We are ever mindful of our responsibilities as a 
corporate citizen.  We know our source of sustainable competitive 
advantage is our employees.

     In 1995 we enjoyed growth across all product lines and in all 
markets, both domestic and international.  This was the result of 
our on-going effort to run our business more efficiently, the 
improved economy worldwide, and the Allied-Kelite acquisition.  1995 
was better than we expected.

     This year's annual report is evidence of our increased 
attention to cost within MacDermid.  The simple black and white 
format resulted in lower cost.  We know that elaborate reports do 
not lower cost or increase revenues - our clearly understood 
objectives.

     Our effort to improve efficiency is Company-wide in all markets 
and in all functions.  In Europe we completed restructuring in a 
number of countries, reducing costs and improving effectiveness.  As 
a result, today we are not only more competitive but more 
profitable.  The same is true in every country in which we operate.  
This is important since some 52% of sales are outside the United 
States. 

     Our effort to improve effectiveness is not focused solely on 
costs.  We believe effectiveness is also measured in terms of 
customer satisfaction.  We place a high priority not only on product 
quality but on the quality of service we give to our customers.  We 
are committed to Total Quality Management, and teams are in place 
throughout the Company.  For example:

     .CUSTOMER SATISFACTION TEAM
      This team, in its second year, is charged with understanding 
      what our customers think of MacDermid and helping us respond 
      to their suggestions.  The team's actions are supported with 
      hard data gathered through formal survey procedures.

     .ISO 9002
      We received this international certification in all major    
      manufacturing plants:  England, Spain, Taiwan, Connecticut and 
      Michigan.

     .ON TIME DELIVERY TEAM
      This team is charged with monitoring and improving our 
      performance in meeting our customers' shipment requirements.  
      We have made considerable progress and we expect more.

     .PRODUCT DEVELOPMENT PROTOCOL TEAM
      We are working to reduce the cycle time and improve the 
      success ratio in new product development.

     Research and development has always been an important priority 
for MacDermid.  We do not look upon R&D as a discretionary 
expenditure.  In 1995, our R&D investment was $9.6 million compared 
with $6.7 million in 1994.  R&D, like our acquisition effort, is 
focused not only on broadening and improving our product line 
serving current markets, but also on new products in new markets, all
within our core competencies.  This is a long-term, on-going effort. 

* Before the effects of accounting changes


     In May of 1994 MacDermid acquired the metal finishing business 
of Allied-Kelite (A.K.).  We thought it a perfect fit for our metal 
finishing business as they were strong in markets we were not.  
Their product line complements ours.  Importantly, with A.K. came 
outstanding people.  Because of the competent people within A.K. and 
within MacDermid, the merger of the two businesses went smoothly, 
and the results were better than expected.

     In August of 1994 we repurchased, through a tender offer, 
approximately 852,000 shares, 24% of our outstanding stock.  The 
tender offered shareholders who wished to sell a price substantially 
higher than the market.  It gave shareholders who wished to remain 
shareholders, in essence, a dividend.  The reduced number of share 
outstanding gave each remaining shareholder 31% more of our future.

     Because of our improved cash flow and improved balance sheet, 
we were able to finance the acquisition of Allied-Kelite and the 
tender offer with added debt.  Our cash flow is at record levels.  
Our debt/capital ratio is 34%.  Our total debt is little more today 
than it was in 1990 when our earnings were $1.49 per share and our 
cash flow was considerably less.  Nevertheless, at this juncture, a 
dividend increase is not planned by your Board of Directors.  The 
Board believes shareholders are better served by utilizing excess 
cash flow to reduce our debt and/or to grow the Company internally 
and through acquisitions.  We are aware that each dollar invested 
should produce at leas one added dollar of intrinsic value to our 
business.

     While a lot of things have been changing at MacDermid, one 
thing has not - our Corporate Philosophy.  It is published, as 
usual, on the inside cover of our annual report.  Everyone at 
MacDermid is dedicated to conducting our business in accordance with 
that Philosophy.

     At MacDermid, we know we work for our shareholders.  We know 
our stewardship will be measured, over the years, in per share 
terms.  This is encouraged by the widespread and significant stock 
ownership within the Company.  Through our ESOP and other plans, we, 
your employees, own 24% of the outstanding shares.

     This year, three of our senior Directors are not standing for 
reelection, having reach Board retirement age.  Walter Torrance, 
Robert Welzien and Francis White have served your Company with 
distinction.  Their advice, judgment and support will be missed.  We 
know all shareholders join us in thanking them and wishing them 
well.

     We begin fiscal 1996 in the best shape ever.  While fiscal 1995 
results have undoubtedly been helped by the economy here in the 
United States and internationally, they are also the result of a 
four-year effort to reorganize and refocus our business.

     Our effort to improve and grow is an everyday effort.  We are 
working to make what has been accomplished but a beginning.

     We want to thank all of our associates at MacDermid who have 
worked hard and effectively to produce an outstanding fiscal 1995, 
and our shareholders for their confidence.


/s/ Harold Leever                    /s/ Daniel H. Leever

Harold Leever                        Daniel H. Leever
Chairman of the Board                President and Chief Executive Officer

<PAGE>
<TABLE>
                                 MACDERMID, INCORPORATED AND SUBSIDIARIES
                                       FIVE YEAR OPERATIONS REPORT

(In thousands, except per share amounts)                          Year Ended March 31
                                                --------------------------------------------------------
<CAPTION>
                                                  1995         1994        1993        1992      1991
                                                --------------------------------------------------------
<S>                                            <C>         <C>         <C>         <C>        <C>
Net Sales:
    Proprietary chemicals                       $163,315     $130,601    $130,132    $115,595   $120,937
    Equipment, chemicals and supplies resale      18,785       19,425      26,192      29,389     30,422 
                                               ---------------------------------------------------------   
                                                 182,100      150,026     156,324     144,984    151,359
Cost of sales                                     94,059       76,914      83,900      79,908     82,175
                                               ---------------------------------------------------------
    Gross profit                                  88,041       73,112      72,424      65,076     69,184
Selling, technical and administrative expenses    67,904       60,063      56,880      54,038     55,938
                                               ---------------------------------------------------------
    Operating profit                              20,137       13,049      15,544      11,038     13,246
Other income (expense):
    Interest income                                  185          300         364         384        368
    Interest expense                              (2,029)      (1,403)     (1,870)     (1,576)    (2,021)
    Foreign exchange                                (291)        (683)       (472)       (392)      (189)
    Other, net                                       145        1,161      (1,228)      1,531        (71)
                                               ---------------------------------------------------------
                                                  (1,990)        (625)     (3,206)        (53)    (1,913)
                                               ---------------------------------------------------------
    Earnings before income taxes and 
     cumulative effect of accounting change       18,147       12,424      12,338      10,985     11,333
Income taxes                                       7,005        4,653       4,651       3,741      4,549
                                               ---------------------------------------------------------
    Earnings before cumulative effect
     of accounting change                         11,142        7,771       7,687       7,244      6,784
Cumulative effect of accounting change              (371)      (2,082)        -           -           -
                                               ---------------------------------------------------------
    Net earnings                                $ 10,771     $  5,689    $  7,687    $  7,244   $  6,784
                                               =========================================================
Earnings per share before cumulative effect 
 of accounting change                              $3.55<F1>    $2.18       $2.16       $2.03      $1.90
Cumulative effect of accounting change             (0.12)       (0.58)        -           -          -
                                               ---------------------------------------------------------
    Net earnings per common share                  $3.43        $1.60       $2.16       $2.03      $1.90
                                               =========================================================
Average number of shares                       3,141,855    3,567,875   3,565,371   3,565,000  3,565,000
                                               =========================================================
<FN>
<F1> For 1995 indicates primary earnings per share.  Fully diluted earnings per share for 1995, the first 
     period during which the dilutive effect was large enough to report, was $3.50 before the cumulative 
     effect of an accounting change and $3.38 after such change.
</TABLE>
<PAGE>
<TABLE>
                                   MANAGEMENT'S DISCUSSION & ANALYSIS OF
                                 FINANCIAL CONDITION & RESULTS OF OPERATIONS
 
                                            FIVE YEAR SUMMARY
<CAPTION>
(In thousands, except per share amounts)         1995       1994        1993        1992        1991
                                              --------------------------------------------------------
<S>                                           <C>         <C>         <C>         <C>         <C>
Net Sales:
    North America                             $ 93,867    $ 78,861    $ 74,068    $ 73,119    $ 79,881
    Overseas                                    88,233      76,165      82,256      71,865      71,478
                                              --------------------------------------------------------
                                              $182,100    $150,026    $156,324    $144,984    $151,359
                                              ========================================================
Net Earnings<F1>                              $ 11,142    $  7,771    $  7,687    $  7,244    $  6,784
Net Earnings per Common Share<F1><F2>            $3.55       $2.18       $2.16       $2.03       $1.90
Cash Dividends Declared per Share                $0.60       $0.60       $0.60       $0.60       $0.60
Total Assets                                  $123,305    $105,867    $107,173    $101,214    $103,252
Long Term Obligations - non current           $ 18,229    $    922    $    983    $  1,348    $  1,940
<FN>
<F1> Before cumulative effect of accounting changes which resulted in one-time after tax charges of 
     $371,000 ($0.12/share) in 1995 and $2,082,000 ($0.58/share) in 1994.

<F2> For 1995 indicates primary earnings per share.  Fully diluted earnings per share were $3.50 for 
1995, the first period during which the dilutive effect was large enough to report.
</TABLE>


NET SALES & OPERATING PROFITS

OVERVIEW

Worldwide proprietary chemical sales were $163.3 million, an 
increase of 25% in fiscal 1995 over the previous year's record 
levels.  This increase reflects the effects of new accounts in 
every geographic segment, improving business conditions and a 
business acquisition in the U.S.  Total sales of $182.1 million, 
which increased 21%, were affected by a change during fiscal 1994 
to an agency basis for certain products previously resold.

Net earnings increased for the fifth consecutive year to 
$11,142,000, $3.55 per share, as compared to fiscal 1994 net 
earnings of $7,771,000, $2.18 per share (before deducting for 
the cumulative effect of accounting changes in each year).


NORTH AMERICA
1995 vs 1994

Total net sales increased in North America 27% because of a 
strengthening economic climate strongly enhanced by the effects 
of the purchase of Allied-Kelite's proprietary chemical business 
during the first quarter of fiscal 1995 and despite reduced 
direct sales of process equipment.  

     During the transition period following the acquisition of 
assets,costs of sales were affected by inventory purchased from 
Allied-Kelite at prices higher than MacDermid's normal replacement 
costs.

     Selling, technical and administrative expenses increased 
principally as a result of additional sales and research 
personnel hired in connection with the Allied-Kelite business, 
continuing development of imaging products, and employee 
incentives related to higher earnings levels.

     An increase in interest expense resulting from borrowings 
to finance a common stock repurchase was more than offset by an 
increase in the Corporation's share of earnings from Hollmuller 
America, a joint venture manufacturer of high quality, 
precision, modular, horizontal production equipment used by 
printed circuit and chemical machining industries, plus the 
effects of higher royalties received on overseas sales and 
reduced foreign exchange losses.

     During the first quarter of fiscal year 1995, the 
Corporation acquired certain assets of the Allied-Kelite Company 
(a subsidiary of Witco Corporation), a major supplier of plating 
surface preparation proprietary chemical products to automotive and 
electronics hardware industries.  The business, located primarily in 
the United States, includes licenses of technology to companies in 
several other countries.  The acquisition cost (approximately $8.9 
million), financed through short-term borrowings, included 
inventories,a research facility and technology.  The acquisition, 
accounted for as a purchase, is producing consolidation cost 
benefits in addition to improved domestic sales coverage.

     During fiscal 1995, the Corporation adopted the provisions 
of Statement of Financial Accounting Standards No. 112, 
Employers' Accounting for Postemployment Benefits (SFAS 112).  
SFAS 112 requires accrual accounting for recognition of the 
postemployment cost of salary continuation benefits rather than 
the previously used cash basis accounting.  Adoption of SFAS 112 
resulted in a one-time $371,000 charge against earnings, net of 
income taxes.  The ongoing expense effects are not material to 
the consolidated financial statements.

1994 vs 1993

In fiscal 1994, sales of proprietary chemical products began a 
recovery from the U.S. recession which started in fiscal 1990.  
Operating profits increased despite additional spending for 
research and market development in support of new programs.  Net 
earnings in North America reflect the effects of a decline in 
royalty income because of lower covered sales overseas.  
Hollmuller America, Inc., a joint venture with a German partner, 
reported profits for the first time in fiscal 1994 reflecting 
aggressive cost reductions and standardization of certain 
equipment offerings.  End of year sales backlogs were greatly 
improved over the previous year.

     During fiscal 1994, the Corporation adopted the provisions 
of Statement of Financial Accounting Standards No. 106, 
Employers' Accounting for Postretirement Benefits Other than 
Pensions (SFAS 106).  Adoption of the accrual accounting, 
required by SFAS 106, resulted in a one-time charge against 
earnings, net of income taxes, of $2,082,000 in recognition of 
the postretirement cost of health benefits.  The effect upon 
ongoing expense is not material.


EUROPE
1995 vs 1994

Net sales for the European group (which includes operations in 
Israel and South Africa) increased almost 9% despite a change 
in the marketing of certain resale products to an agency basis 
which was completed during fiscal 1994.  (MacDermid now receives 
a commission on the covered products.)  Proprietary chemical 
product sales, which account for 84% of the group's business, 
were generally improved throughout the area.

     Selling, technical and administrative expenses were reduced 
overall by over 6% from fiscal 1994 to size the operations more 
appropriately for the level of sales achieved.  Operating 
profits in fiscal 1995 were almost double those of the previous 
year reflecting, in large measure, the effects of proprietary 
chemical sales increases and the expense reductions made in 
Germany during fiscal years 1994 and 1995.

1994 vs 1993

The group's net sales for fiscal 1994 were $38 million compared 
to $45 million for fiscal 1993.  The sales decline was 
principally the result of changing currency exchange rates, 
which accounted for $4.8 million, and the change in marketing of 
certain resale products which accounted for another $1.1 
million.  Actual proprietary chemical sales were little changed 
overall, in terms of local currency, despite the effects of 
severe recession in Germany.

     Net earnings for the group were marginal in fiscal 1994 
because no tax benefit was recorded in connection with 1994 
losses in Germany and because of expenses incurred to make group 
operations more efficient.

ASIA/PACIFIC
1995 vs 1994

Total net sales for the Asia/Pacific group increased 23% to $47 
million in fiscal year 1995 and earnings before income taxes 
increased 31%.  The sales increase was principally due to new 
business in expanding markets, enhanced by economic recovery in 
certain areas, with only a small effect late in the fiscal year 
from a rapidly strengthening Japanese yen.  Costs of sales 
percentages were down 2% as sales of proprietary chemical 
products grew much faster than sales of equipment and resale 
chemicals.

     Selling, technical and administrative expenses rose 
8% as a new research and technical center in Japan was fully 
operational throughout the year and some additional expenses 
were incurred to support the higher sales levels.  Other income 
and expense for fiscal 1995 includes profit on the sale of 
certain office and warehouse property following expansion into 
new quarters.  This income, however, was offset by additions to 
reserves to cover losses by a joint venture operation, higher 
levels of foreign exchange losses on transactions and increased 
royalties paid to the parent company due to increased sales.  
Profits recorded in fiscal 1994 on sales of a minority interest 
in a Hong Kong company were not repeated in fiscal 1995.  

1994 vs 1993

Total net sales of $38.2 million in fiscal 1994 were about 3% 
above the previous year.  The group achieved real proprietary 
chemical sales growth with some benefit from favorable currency 
changes.  Profits from sales of a minority interest in a Hong 
Kong company and profits from sales of property more than offset 
increased costs related to a new research group in Japan and a 
charge against earnings for a bad debt loss.  Net earnings were 
14% above fiscal year 1993.


INTEREST EXPENSE

Interest expense, net of interest income, in fiscal 1995, 
increased by $741,000 over fiscal 1994 following a decrease of 
$403,000 from the previous year.  The increase in 1995 was due 
principally to U.S. borrowings in August 1994 to finance the 
purchase of treasury stock pursuant to a self-tender offer and 
to an increase in short-term borrowings to finance the Allied-
Kelite business acquisition.  The 1994 decrease was attributable 
to repayments of borrowings and generally lower interest rates 
than in 1993.


INCOME TAXES

Overall effective income tax rates increased slightly  to 38.6% 
in fiscal 1995 from 37.5% in fiscal 1994 as compared to 37.7% 
in fiscal 1993.  The 1995 increase and the 1994 decrease were 
principally attributable to changes in the amounts included in 
each year's earnings before income taxes for non taxable one-
time profits on sales of property and minority equity interests, 
a 1995 non tax-deductible charge for losses in a joint venture 
and 1994 losses in a subsidiary where tax benefits were not 
recognized until 1995.


DIVIDENDS

MacDermid has paid cash dividends out of accumulated earnings 
continuously since 1948.  The total dividend paid for fiscal 
1995 was $0.60 per share or approximately 16% of net earnings 
before the cumulative effect of an accounting change.

LIQUIDITY & CAPITAL RESOURCES

Cash flows from operations are used to fund dividend payments to 
shareholders, other working capital requirements of the 
Corporation and most capital projects.  From time to time 
MacDermid utilizes additional outside sources to fund overall 
needs, including major capital projects for new and upgraded 
research and technical, manufacturing and administrative 
facilities, and for business acquisitions.  During the last 
several years, most of the funds previously provided by such 
outside sources have been repaid utilizing cash flows from 
operations and from disposition of certain business and 
properties no longer required after consolidation of 
manufacturing and other operations.  Total borrowings, which 
were over $26 million at March 31, 1990, were reduced to $9 
million by the end of fiscal 1994.  Early during fiscal 1995, 
MacDermid purchased certain assets used in Allied-Kelite's metal 
finishing business for approximately $8.9 million, financed 
through short-term loans.  Subsequently (August 1, 1994), the 
Corporation completed the purchase of approximately 852,000 
shares of MacDermid's common stock under a self-tender offer at 
a price of $30 per share.  The total cost of this purchase, 
including commitment fees, professional costs, etc., was 
approximately $26.2 million, financed through a six-year term loan 
with a group of banks.  (This loan is further discussed in note 
7 to the Consolidated Financial Statements.)  Because of the 
strong cash flows generated by operations and sales of certain 
assets, total debt at March 31, 1995 is approximately $27 
million.

     New capital spending during fiscal 1995 of approximately $4 
million, as compared with $7.5 million in fiscal 1994 and $4.5 
million in fiscal 1993, included upgrades to manufacturing 
facilities and new equipment to provide for the transfer of 
Allied-Kelite manufacturing operations to existing facilities 
and technical equipment.  For fiscal 1996, planned new capital 
projects total approximately $5 million.

     New opportunities for business acquisitions, which become 
available from time to time, are evaluated individually as they 
arise based upon MacDermid's criteria for technological 
improvement and innovation, potential for earnings growth and 
compatibility with existing manufacturing capability and 
distribution channels.  Management intends to pursue those 
opportunities which have strong potential to enhance shareholder 
value.

     The Board of Directors has, from time to time, authorized 
the purchase of issued and outstanding shares of the 
Corporation's common stock for its treasury.  Following the 
August 1, 1994 completion of the self-tender offer, the 
directors authorized the purchase of up to an additional 148,000 
shares of MacDermid's common stock.  Pursuant to this 
authorization, MacDermid acquired 11,000 shares  in December 
1994 in a privately negotiated purchase.  Treasury shares may be 
used for transfer or sale to employee benefit plans, business 
acquisitions or for other Corporate purposes.  The outstanding 
authorization to purchase up to 137,000 shares, if exercised at 
the Nasdaq Stock Market closing price on March 31, 1995, would 
cost approximately $5.9 million.

<TABLE>
     The principal sources and uses of cash in fiscal years 1995 
and 1994 were as follows:
<CAPTION>
(In Thousands)                      1995            1994
                                  ------------------------
<S>                               <C>              <C>
Cash provided by:
  Operations                      $20,733          $15,766
  Proceeds from dispositions of
    fixed assets and certain
    business                        3,376            2,998
  Net increase in borrowings       17,718              -
                                  ------------------------
                                  $41,827          $18,764
                                  ========================

Cash used for:
  Capital expenditures            $ 3,990          $ 7,526
  Business acquisitions             8,910              -
  Purchase of treasury shares      26,152              -
  Dividend payments                 1,767            2,141
  Net decrease in borrowings          -              7,295
  Other - net                        (138)           1,149
                                  ------------------------
                                  $40,681          $18,111
                                  ========================
</TABLE>

     MacDermid's financial position is strong and, other than 
satisfaction of debt obligations, there are no long-range 
commitments which would have a significant impact upon results 
of operations, financial condition or liquidity.  At March 31, 
1995 the Corporation had unused domestic and foreign short-term 
credit lines with banks approximating $43 million and management 
believes that additional borrowing could be obtained if needed.


INFLATION AND CHANGING PRICES

MacDermid operates principally in stable areas throughout the 
world.  Sales are mainly to companies whose outputs become 
components in consumer and industrial products having wide 
application and demand and no one customer accounts for a 
material proportion of sales.  Management, therefore, believes 
that inflation, generally, has had little overall impact upon 
the Corporation's operations and reported earnings.  While there 
may be temporary disruptions of economic stability, management 
believes that their long-term effects will not be significant to 
the Corporation.


ENVIRONMENTAL ACTIVITIES

MacDermid continues its commitment to an active program of 
environmental responsibility through its Environmental Initiative 
2000 program, research and development of alternative, 
environmentally safer products and installation of equipment to 
reduce or eliminate emissions.

     The Corporation sponsors community clean-up programs and 
promotes community awareness of environmental issues.  The terms of 
a State of Connecticut permit require MacDermid to have periodic 
environmental compliance and environmental management audits 
performed at its Waterbury, Connecticut facility.  These audits take 
place over a five-year period which commenced in 1993.  An 
environmental consultant retained by MacDermid conducts the audits 
and submits appropriate recommendations.

     MacDermid continuously conducts research to formulate products 
which are environmentally friendly and which provide superior 
operating characteristics in customer applications.  Many companies 
have come to MacDermid for assistance in meeting their environmental 
needs.  

     Environmental expenditures that relate to current operations 
are expensed; long-term betterments are capitalized.  The 
expenditure by MacDermid for these various programs is estimated to 
be in excess of $1 million per year.  MacDermid has been named as a 
potentially responsible party (PRP) by the Environmental Protection 
Agency in connection with two waste sites.  There are many other 
companies involved at each of these sites and MacDermid's 
participation is minor.  The Corporation has recorded its best 
estimate of liabilities in connection with site clean-up based upon 
the extent of its involvement, the number of PRPs and estimates of 
the total costs of the site clean-up.  Though it is difficult to 
predict the final costs of site remediation, management believes 
that the recorded liabilities are reasonable estimates of probable 
liability and that future cash outlays are unlikely to be material 
to financial condition, results of operations or cash flows.



<PAGE>
<TABLE>
                                   CONSOLIDATED STATEMENTS OF EARNINGS 
                                            
                                                                         Year Ended March 31
                                                                -------------------------------------
<CAPTION>
(In thousands, except share and per share amounts)                1995           1994          1993
                                                                -------------------------------------
<S>                                                           <C>            <C>           <C>
Net sales: 
    Proprietary chemicals                                       $163,315       $130,601      $130,132
    Equipment, chemicals and supplies resale                      18,785         19,425        26,192
                                                                -------------------------------------
                                                                 182,100        150,026       156,324
Cost of Sales                                                     94,059         76,914        83,900
                                                                -------------------------------------
    Gross profit                                                  88,041         73,112        72,424

Selling, technical and administrative expenses                    67,904         60,063        56,880
                                                                -------------------------------------
    Operating profit                                              20,137         13,049        15,544

Other income (expense):
    Interest income                                                  185            300           364
    Interest expense                                              (2,029)        (1,403)       (1,870)
    Foreign exchange                                                (291)          (683)         (472)
    Miscellaneous, net                                               145          1,161        (1,228)
                                                                -------------------------------------
                                                                  (1,990)          (625)       (3,206)
                                                                -------------------------------------
    Earnings before income taxes and cumulative
      effect of accounting change                                 18,147         12,424        12,338
Income taxes (note 5)                                              7,005          4,653         4,651
                                                                -------------------------------------
    Earnings before cumulative
      effect of accounting change                                 11,142          7,771         7,687
Cumulative effect of accounting change (note 4)                     (371)        (2,082)          -
                                                                -------------------------------------
    Net earnings                                                $ 10,771       $  5,689      $  7,687
                                                                =====================================
Net earnings per share (note 1):
   Primary 
      Before cumulative effect of
        accounting change                                          $3.55          $2.18         $2.16
      Cumulative effect of accounting change (note 4)              (0.12)         (0.58)           - 
                                                              ---------------------------------------
                                                                   $3.43          $1.60         $2.16
                                                              =======================================
   Fully diluted 
      Before cumulative effect of 
        accounting change                                         $3.50           $2.18         $2.16
      Cumulative effect of accounting changes (note 4)            (0.12)          (0.58)           -
                                                              ---------------------------------------
                                                                  $3.38           $1.60         $2.16
                                                              =======================================

Weighted average number of shares outstanding (note 1)
   Primary                                                    3,141,855       3,567,875     3,565,371
                                                              =======================================
   Fully Diluted                                              3,179,832       3,567,875     3,565,371
                                                              =======================================
<FN>
                       See accompanying notes to consolidated financial statements.
</TABLE>
<PAGE>
<TABLE>
                                    CONSOLIDATED BALANCE SHEETS

ASSETS                                                                           March 31
                                                                      -----------------------------
<CAPTION>
(In thousands)                                                          1995                 1994
                                                                      -----------------------------
<S>                                                                   <C>                  <C>
Current assets:
    Cash and equivalents                                              $  7,630             $  6,484
    Accounts receivable, less allowance for doubtful receivables
      of $2,859 and $2,317                                              45,559               39,738
    Inventories (note 2)                                                22,801               17,744
    Prepaid expenses                                                     2,052                1,380
    Deferred income taxes                                                3,155                3,069
                                                                      -----------------------------
                                                                        81,197               68,415
        Total current assets                                          -----------------------------

Property, plant and equipment, at cost:
    Land and improvements                                                2,829                2,590
    Buildings and improvements                                          26,346               26,190
    Machinery, equipment and fixtures                                   33,581               31,699
                                                                      -----------------------------
                                                                        62,756               60,479
    Less accumulated depreciation and amortization                      35,721               32,690
                                                                      -----------------------------
    Net property, plant and equipment                                   27,035               27,789
                                                                      -----------------------------
Other assets                                                            15,073                9,663
                                                                      -----------------------------
                                                                      $123,305             $105,867
                                                                      =============================
</TABLE>


















<PAGE>
<TABLE>
LIABILITIES & SHAREHOLDERS' EQUITY                                               March 31
                                                                      -----------------------------
<CAPTION>
(In thousands, except share and per share data)                          1995                 1994
                                                                      -----------------------------
<S>                                                                   <C>                  <C>
Current liabilities:
    Notes payable (note 3)                                            $  4,720             $  7,609
    Current installments of long-term obligations (note 7)               4,413                  429
    Accounts payable                                                    18,064               12,961
    Dividends payable                                                      411                  535
    Accrued compensation                                                 6,089                2,588
    Accrued expenses, other                                              7,258                6,663
    Income taxes (note 5)                                                5,531                2,671
                                                                      -----------------------------
        Total current liabilities                                       46,486               33,456
                                                                      -----------------------------
Long-term obligations (note 7)                                          18,229                  922
Accrued postretirement benefits (note 4)                                 3,899                3,214
Deferred income taxes (note 5)                                             960                  106
Shareholders' equity (note 9):
    Preferred stock, authorized 2,000,000 shares; none issued             -                     -
    Common stock.  Authorized 20,000,000 shares; issued
      4,136,080 and 4,098,530 shares at stated value of 
      $1.00 per share (note 4)                                           4,136                4,099
    Additional paid-in capital (note 4)                                  1,676                  834
    Retained earnings                                                   84,043               75,039
    Equity adjustment from foreign currency translation                  1,551                 (203)
    Less cost of 1,393,547 and 530,648 common shares in treasury       (37,752)             (11,600)
                                                                      ------------------------------
        Total shareholders' equity                                      53,654               68,169
                                                                      ------------------------------
Contingencies and commitments (notes 8 and 10)

                                                                      $123,305             $105,867
                                                                      ==============================
<FN>
                    See accompanying notes to consolidated financial statements.
</TABLE>













<PAGE>
<TABLE>
                               CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                         Year Ended March 31
                                                              ---------------------------------------  
<CAPTION>
(In thousands)                                                   1995            1994          1993
                                                              ---------------------------------------
<S>
Cash flows from operating activities:                         <C>               <C>           <C>
    Net earnings                                              $ 10,771          $ 5,689       $ 7,687
    Adjustments to reconcile net earnings to net cash
      provided by operating activities:
         Depreciation                                            4,349            4,596         4,745
         Effect of change in accounting (note 4)                   371            2,082            -
         Amortization of goodwill and other intangible assets      685            1,011           911
         Provision for bad debts                                   664            1,792         1,797
         Deferred income taxes                                  (1,420)            (422)         (518)
    Changes in assets and liabilities net of effects
      from acquisitions and dispositions:
         Decrease (increase) in receivables                     (4,685)           1,090        (7,822)
         Decrease (increase) in inventories                       (265)             931         1,870
         Decrease (increase) in prepaid expenses                  (713)            (111)         (362)
         Increase (decrease) in accounts payable                 4,453           (1,697)         (989)
         Increase (decrease) in accrued expenses                 3,505            2,094         2,171
         Increase (decrease) in income tax liabilities           2,860              596           (26)
         Other                                                     158           (1,885)         (122)
                                                              ---------------------------------------
          Net cash flows provided by operating activities       20,733           15,766         9,342
                                                              ---------------------------------------
Cash flows from investing activities:
    Capital expenditures                                        (3,990)          (7,526)       (4,594)
    Proceeds form disposition of fixed assets                    3,376            2,998           916
    Acquisitions of business                                    (8,910)             -          (2,259)
    Other investments                                             (216)          (1,062)         (662)
                                                              ---------------------------------------
          Net cash flows used in investing activities           (9,740)          (5,590)       (6,599)
                                                              ---------------------------------------
Cash flows from financing activities:
    Long-term and short-term borrowings                         26,609            1,943         5,814
    Long-term and short-term repayments                         (8,891)          (9,238)       (5,003)
    Acquisition of treasury stock (note 9)                     (26,152)             -             -
    Dividends paid                                              (1,767)          (2,141)       (2,139)
                                                              ---------------------------------------
          Net cash flows used in financing activities          (10,201)          (9,436)       (1,328)
                                                              ---------------------------------------
Effect of exchange rate changes on cash
  and equivalents                                                  354              (87)         (216)
                                                              ---------------------------------------
Net increase in cash and equivalents                             1,146              653         1,199
Cash and equivalents at beginning of year                        6,484            5,831         4,632
                                                              ---------------------------------------
Cash and equivalents at end of year                           $  7,630          $ 6,484       $ 5,831
                                                              =======================================
Cash paid for interest                                        $  2,182          $ 1,627       $ 1,823
                                                              =======================================
Cash paid for income taxes                                    $  4,226          $ 4,398       $ 4,768
                                                              =======================================
<FN>
                  See accompanying notes to consolidated financial statements.
</TABLE> 














































<PAGE>
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a) Principles of Consolidation.  The accompanying consolidated 
financial statements include accounts of the parent corporation and 
all of its domestic and foreign subsidiaries.  Certain foreign 
subsidiaries, for practical purposes, are included on a calendar 
year basis.  All significant intercompany accounts and transactions 
have been eliminated in consolidation.

(b) Acquisition.  In May 1994 the Corporation acquired certain 
assets of the U.S. based Allied-Kelite Company from Witco 
Corporation.  Chemical products produced by Allied-Kelite include 
plating and surface preparation proprietary chemical products which 
are sold to customers in the aerospace, automotive and electronics 
hardware industries.  Certain technology was also acquired which is 
licensed to several customers in specific overseas markets. The 
total purchase price for the acquisition was approximately $8.9 
million including inventory, fixed assets, goodwill (being amortized 
over 15 years) and other intangibles.  Total assets and pretax 
earnings resulting from the purchase were less than 10% of the 
Corporation's consolidated total assets and pretax earnings before 
acquisition.  The acquisition was accounted for as a purchase 
transaction.  Consolidated operating results for fiscal 1995 include 
the results of the Allied-Kelite business from May 2, 1994.  

(c) Inventories.  Inventories are stated at the lower of cost 
(average moving cost) or replacement market.

(d) Property, Plant and Equipment.  Property, plant and equipment 
are stated at cost.  Depreciation and amortization of property, 
plant and equipment are provided over the estimated useful lives of 
the respective assets, principally on the straight-line basis.  
Expenditures for maintenance and repairs are charged directly to 
expense; renewals and betterments, which significantly extend the 
useful lives, in general are capitalized.  Costs and accumulated 
depreciation and amortization on assets retired or disposed of are 
removed from the accounts and the gains or losses resulting 
therefrom, if any, are credited or charged to earnings.

(e) Employee Benefits.  The Corporation sponsors a variety of 
employee benefit programs, most of which are non-contributory.

  Retirement.  Pension, profit sharing and other retirement plans 
generally are non-contributory and cover substantially all 
employees.  Domestically, the Corporation funds a pension plan based 
upon plan costs accrued in accordance with the principles of 
Statement of Financial Accounting Standards No. 87.  The projected 
unit credit actuarial method is used for financial reporting 
purposes.  The pension plan provides retirement benefits based upon 
years of service and compensation levels.  In addition, the 
Corporation contributes to profit sharing and employee stock 
ownership plans which provide retirement benefits based upon amounts 
credited to employee accounts within the plans. The Corporation's 
funding policy for qualified plans is consistent with federal or 
other regulations and customarily equals the amount deducted for 
income tax purposes.  Foreign subsidiaries contribute to plans which 
may be administered privately or by government agencies in 
accordance with local regulations.

  Postretirement.  The Corporation has postretirement health care 
benefits for most employees.  Effective April 1, 1993, the 
Corporation adopted Statement of Financial Accounting Standards No. 
106, Employers' Accounting for Postretirement Benefits Other than 
Pensions (SFAS 106), for its domestic plan.  For its foreign plans 
the effect was immaterial.  SFAS 106 requires accrual accounting for 
all postretirement benefits other than pensions rather than the 
previously used pay-as-you-go method.  The postretirement health 
care plan is unfunded.

  Postemployment.  The Corporation provides postemployment 
disability benefits to employees meeting specified service 
requirements.  Effective April 1, 1994, the Corporation adopted 
Statement of Financial Accounting Standards No. 112, Employers' 
Accounting for Post Employment Benefits (SFAS 112). SFAS 112 
requires accrual for such benefits if the obligation is attributable 
to employees' services already rendered, employees' rights to those 
benefits accumulate or vest, payment of the benefits is probable, 
and the amount of the benefits can be reasonably estimated.

(f) Research and Development.  Research and development costs, 
charged to expenses as incurred, were $9,644,000, $6,687,000 and 
$5,796,000 in 1995, 1994 and 1993, respectively.

(g) Income Taxes.  In fiscal year 1993 the Corporation adopted 
Statement of Financial Accounting Standards No. 109, Accounting for 
Income Taxes (SFAS 109), which requires the use of the liability 
method of accounting for deferred income taxes.  Pursuant to SFAS 
109, the provision for income taxes includes Federal, foreign, state 
and local income taxes currently payable and those deferred because 
of temporary differences between the financial statement and tax 
bases of assets and liabilities.  No provision for deferred income 
taxes is made with respect to equity adjustments from foreign 
currency translation or to undistributed earnings of subsidiaries 
which, in management's opinion, will be permanently reinvested or 
repatriated at a minimal tax cost to the Corporation.  Foreign tax 
credits are recorded as a reduction of the provision for Federal 
income taxes in the year realized.

(h) Foreign Operations.  The balance sheet accounts of foreign 
subsidiaries are translated into U.S. dollars at year-end rates of 
exchange while revenue and expense accounts are translated at 
weighted average rates in effect during the periods.  Translation of 
the balance sheets resulted in an increase in equity of $1,754,000 
in 1995 and decreases in equity of $781,000 and $1,569,000 in 1994 
and 1993, respectively.  Gains and losses on foreign currency 
transactions are included in the consolidated statements of 
earnings.
(i) Cash and Equivalents.  For the purpose of the consolidated 
statements of cash flows, the Corporation considers all highly 
liquid debt instruments purchased with a maturity of three months or 
less to be cash equivalents.

(j) Fair Value of Financial Instruments.  Statement of Financial 
Accounting Standards No. 107 requires that reporting entities 
provide, to the extent practicable, the fair value of financial 
instruments, both assets and liabilities.  The carrying amounts for 
the Corporation's financial instruments approximate fair value 
because of the short maturity of those instruments.  The carrying 
values of other financial instruments approximate fair value or are 
not material to the balance sheets.

(k) Earnings Per Common Share.  The computation of primary earnings 
per share is based upon the weighted average number of outstanding 
shares plus (in periods in which they have a dilutive effect) the 
effect of common shares contingently issuable from stock options. 
The fully diluted per share computations also reflect additional 
dilution related to stock options due to the use of the market price 
at the end of the period, when higher than the average price for the 
period.  Fiscal 1995 is the only year presented for which the 
dilutive effect was large enough to report.

<TABLE>
2.  INVENTORIES

The major components of inventory at March 31 were as follows:
<CAPTION>
(In thousands)                                       1995           1994
                                                   ----------------------
<S>                                                <C>            <C>
Finished goods                                     $16,074        $13,091
Raw materials and supplies                           6,727          4,653
                                                   ----------------------
                                                   $22,801        $17,744
                                                   ======================
</TABLE>

3.  NOTES PAYABLE

Notes payable at March 31, 1995 consisted primarily of $4,720,000 of 
outstanding borrowings under available lines of credit aggregating 
approximately $48,000,000.  The terms of the lines of credit 
generally provide for interest rates at or below the prime rate on 
the date of borrowing domestically and, for foreign company 
borrowings, rates that vary with base rates in each currency.  With 
the exception of a $10 million committed revolving credit line, the 
lines of credit can be withdrawn at any time at the option of the 
banks.  The weighted average interest rates on short-term borrowings 
outstanding were 5.1% and 7.9% at the end of 1995 and 1994, 
respectively.

4.  EMPLOYEE RETIREMENT & WELFARE PLANS
The Corporation has defined benefit pension, defined contribution 
profit sharing and employees' stock ownership plans, each of which 
is funded annually, as required, for substantially all its domestic 
employees.  Aggregate amounts charged to earnings for these plans 
were $1,791,000, $1,194,000 and $971,000 in 1995, 1994 and 1993, 
respectively.

<TABLE>
Pension.  Net pension cost of the Corporation's defined benefit plan
included the following components for the years ended March 31:
<CAPTION>
(In thousands)                          1995         1994         1993
                                     ---------------------------------
<S>                                  <C>          <C>          <C>
Service cost                         $   581      $   557      $   564
Interest cost                          1,158        1,119        1,012
Actual return on investment           (1,879)        (238)      (1,511)
Net amortization and deferrals           341       (1,320)          36
                                     ---------------------------------
Net periodic pension cost            $   201      $   118      $   101
                                     =================================
</TABLE>

   The rate of increase in future compensation levels used in 
determining the actuarial present value of the projected benefit 
obligation was 5% for 1995, 4% for 1994 and 5% for 1993.  The 
expected long-term rate of return on assets was 9% for 1995, 1994 
and 1993, and the weighted average settlement rate was 8% for 1995, 
7.5% for 1994 and 8.25% for 1993.  

<TABLE>
   The following table sets forth the plan's funded status at March 
31, 1995 and 1994 and the amount recognized in the Corporation's 
consolidated balance sheet at March 31:
<CAPTION>
(In thousands)                                       1995           1994
                                                   -----------------------
<S>                                                <C>             <C>
Actuarial present value of
  benefit obligation:
Accumulated benefit obligation
  including vested benefits of 
  $11,989 and $11,780                              $12,588         $12,421 
                                                   =======================
Projected benefit obligation                       $15,947         $15,115
Plan assets at fair value (primarily
  listed stocks, bonds and guaranteed
  investment contracts)                             16,685          15,130
                                                   -----------------------
Plan assets in excess of 
  projected benefits obligation                        738              15
Unrecognized portion of transition
  asset (being amortized over 14 yrs)               (1,145)         (1,314)
Unrecognized net loss                                  311           1,146
Accrued pension cost                               $   (96)        $  (153)
                                                   =======================
</TABLE>

   Plan assets included 43,695 and 58,695 shares of the 
Corporation's common stock having a market value of $1,879,000 and 
$1,526,000 at March 31, 1995 and 1994, respectively.

   Postretirement benefits.  The Corporation sponsors a defined 
benefit postretirement medical and dental plan that covers all of 
its domestic full-time employees.  Employees who retire after age 55 
with at least 10 to 20 years of service (depending upon the date of 
hire) are eligible.  Current retirees are required to contribute 
toward the cost of the plan until they attain age 65.  All future 
retirees will be required to contribute.  The Corporation's subsidy 
level is subject to a cap which increases by 3% each year.  Retirees 
will be required to contribute the plan cost in excess of the cap in 
addition to other required contributions.

   During fiscal 1994 adoption of SFAS 106 resulted in a one-time 
charge against earnings for the transition obligation for past 
services of $2,082,000 (net of a $1,382,000 deferred income tax 
benefit).  The ongoing additional after tax annual cost to the 
Corporation is not material. 

   The Corporation's postretirement medical and dental plan is 
unfunded.  The accumulated postretirement benefit obligation, 
covering both active and retired employees, was $3,882,000 and 
$3,749,000 at March 31, 1995 and 1994, respectively.  The 
Corporation's accrued postretirement medical and dental benefit 
liability at March 31, 1995 was $3,502,000 consisting of the 
unfunded postretirement benefit obligation of $3,882,000 less the 
unrecognized net loss of $380,000 and at March 31, 1994 was 
$3,419,000 consisting of the unfunded postretirement benefit 
obligation of $3,749,000 less the unrecognized loss of $330,000.

   For measurement purposes, a 10.5% annual rate of increase in the 
per capita cost of covered medical benefits was assumed for fiscal 
1994; the rate is assumed to decrease gradually down to 6% for 
fiscal 2002 and remain at that level thereafter.  No annual rate 
increase is assumed for the dental benefit cost since it is a 
scheduled plan.  The medical cost trend rate assumption has only a 
small effect on the amounts reported due to the cap on contributions 
paid by the Corporation.  Increasing the assumed health care cost 
trend rate one percentage point in each year would increase the 
accumulated postretirement benefit obligation as of March 31, 1995 
by approximately $200,000 (5%).  The aggregate of the service and 
interest cost components of the net periodic postretirement benefit 
cost for fiscal 1995 would increase by approximately $12,000 (4%).

   The weighted average discount rate used in determining the 
accumulated postretirement benefit obligation was 8%, 7.5% and 8.25% 
at March 31, 1995, 1994 and 1993, respectively.  Since the plan is 
unfunded, no assumption is needed as to the long-term rate of return 
on assets.  

<TABLE>
   The net periodic postretirement benefit costs for the years ended 
March 31 were as follows:
<CAPTION>
(In thousands)                                        1995          1994
                                                    --------------------
<S>                                                 <C>           <C>
Service cost                                        $   62        $   47
Interest cost                                          292           279
Net amortization                                        11            -
Recognition of transition obligation
 at April 1, 1993                                       -          3,464
                                                    --------------------
Net periodic postretirement benefit cost            $  365        $3,790
                                                    ====================
</TABLE>

   Postemployment benefits.  The Corporation sponsors a defined 
benefit postemployment compensation continuation plan that covers 
all of its full time domestic employees.  Employees who have 
completed at least six months of service, become permanently 
disabled and are unable to return to work are eligible to receive a 
benefit under the plan.  The benefit may range from one week to a 
maximum of six months of compensation.

   During fiscal 1995 adoption of SFAS 112 resulted in a one-time 
charge against earnings for the transition obligation for past 
services of $371,000 (net of a $248,000 deferred income tax benefit) 
which was recorded on April 1, 1994.  The estimated ongoing 
additional after-tax annual cost of this plan is not material.

   The postemployment salary continuation plan is unfunded.  The 
expected net periodic postemployment benefit cost for salary 
continuation for fiscal 1995 included approximately $2,000 for 
service cost (benefits attributed to service during the period), 
$6,000 for interest cost and $619,000 for recognition of the 
transition obligation at April 1, 1994 for a total net periodic 
postemployment benefit cost of $627,000.  The rate of increase in 
future compensation levels used in determining the actuarial present 
value of the projected benefit obligation was 5% and the weighted 
average settlement rate was 8%.

   Stock option plan.  Under a non-qualified stock option plan 
approved by the Shareholders in July 1992 (the 1992 Plan), certain 
employees have been granted options to purchase up to an aggregate 
294,500 shares of common stock.  During fiscal 1995 there were 
96,500 options granted having an exercise price of $16.1505 and 
8,500 options were canceled upon termination of employment of the 
grantees; during fiscal 1994 there were 73,500 options granted 
having exercise prices from $16.983 to $18.315; and during fiscal 
1993 there were 68,500 options granted having exercise prices from 
$17.649 to $17.982.  Options granted under the 1992 Plan generally 
are exercisable during a four-year period beginning with the grant 
date. Options for 37,550, 500 and 2,382 shares were exercised during 
fiscal years 1995, 1994 and 1993, respectively, at prices ranging 
from $14.652 to $17.982 per share. At March 31, 1995, there were 
254,068 options outstanding with exercise prices from $14.652 to 
$18.315 per share.

   The options are exercisable into restricted shares of common 
stock which cannot be sold or transferred, except back to the 
Corporation at cost, during the four-year period commencing with the 
exercise date.  Compensation expense, which is equal to the 
difference between the fair market value on the date of an option 
grant and the exercise price of shares which may be purchased 
thereunder, is amortized over an estimated combined period from the 
date of grant through the end of the four-year period during which 
purchased shares must be held or resold to the Corporation.  The 
amounts of such compensation expense charged to results of 
operations following the date of grant for the years ended March 31, 
1995, 1994 and 1993 were $370,000, $213,000, and $117,000, 
respectively.

5.  INCOME TAXES

As discussed in Note 1, the Corporation adopted SFAS 109 at the 
beginning of fiscal year 1993.  The cumulative effect of this change 
in accounting for income taxes was immaterial.

   Earnings before income taxes included foreign earnings of 
$11,896,000, $7,864,000 and $7,141,000 for 1995, 1994 and 1993, 
respectively.  

<TABLE>
   Income tax expense attributable to income from operations for the 
years ended March 31 consisted of:
<CAPTION>
(In thousands)                     Current        Deferred        Total
                                   -------------------------------------
                                                    1995
                                                    ----
<S>                                <C>            <C>            <C>
U.S. Federal                       $ 3,887        $  (504)       $ 3,383
State and local                        500             36            536
Foreign                              4,038           (952)         3,086
                                   -------------------------------------
   Totals                          $ 8,425        $(1,420)       $ 7,005
                                   =====================================

                                                    1994
                                                    ----
U.S. Federal                       $ 2,272        $  (434)       $ 1,838
State and local                        590            (86)           504
Foreign                              2,213             98          2,311
                                   -------------------------------------
   Totals                          $ 5,075        $  (422)       $ 4,653
                                   =====================================

                                                    1993
                                                    ----
U.S. Federal                       $ 2,044        $   (44)       $ 2,000
State and local                        663            (12)           651
Foreign                              2,462           (462)         2,000
                                   -------------------------------------
   Totals                          $ 5,169        $  (518)       $ 4,651
                                   =====================================
</TABLE>

<TABLE>
   Income tax expense for the years ended March 31, 1995, 1994 and 
1993 differed from the amounts computed by applying the U.S. Federal 
statutory tax rates to pretax income from operations as a result of 
the following:
<CAPTION>
(In thousands, except tax rates)       1995            1994          1993
                                     ------------------------------------
<S>                                  <C>             <C>           <C>
U.S. Federal statutory tax rate         35%             34%           34%
                                     ====================================
Computed "expected"
  Federal income tax                 $6,351          $4,224        $4,195
State income taxes, net of
  Federal tax benefit                   354             333           429
Adjustment of prior years
   tax accruals                       1,251             (24)          177
Foreign tax rate differential          (132)           (442)         (405)
Change in the beginning of
  the year balance of the
  valuation allowance for
  deferred income taxes 
  allocated to income tax
  expense                              (872)            482            34
No tax benefit for (gain) loss of
  unconsolidated corporate
  joint venture                        (172)            (10)          200
Other, net                              225              90            21
                                   --------------------------------------
   Actual income taxes               $7,005          $4,653        $4,651
                                   ======================================
Effective tax rate                    38.6%           37.5%         37.7%
                                   ======================================
</TABLE>

<TABLE>
   The tax effects of temporary differences that give rise to 
significant portions of the deferred tax assets and liabilities at 
March 31 are:
<CAPTION>
(In thousands)                                        1995        1994
                                                    ------------------
<S>                                                 <C>         <C>
Deferred tax assets:
    Accounts receivable, principally due to
       allowance for doubtful accounts              $  228      $  277
    Inventories, principally due to additional
       costs inventoried for tax purposes pursuant
       to the Tax Reform Act of 1986 and non-
       deductible inventory reserves                   607         420
    Accrued liabilities                              3,527       2,169
    Foreign net operating loss carry forwards        1,198       1,345
    Other                                            1,248         308
                                                    ------------------
        Total gross deferred tax assets              6,808       4,519
    Less valuation allowance                            -          872
                                                    ------------------
        Net deferred assets                          6,808       3,647
Deferred tax liabilities:
    Plant and equipment, principally due to
       differences in depreciation                     773         550
    Other                                              187         166
                                                    ------------------
        Total gross deferred tax liabilities           960         716
                                                    ------------------
        Net deferred asset                          $5,848      $2,931
                                                    ==================
</TABLE>

   The deferred tax asset of $1,198,000 and $1,345,000 at March 31, 
1995 and 1994, respectively, which relate to foreign net operating 
loss carry forwards, results primarily from prior year losses 
incurred by a foreign subsidiary.  The valuation allowance in 1994 
was related to those losses.  The valuation allowance decreased 
$872,000 in 1995 and increased $482,000 in 1994.  Management now 
believes the deferred tax asset is more likely than not to be 
realized from future taxable income generated by the subsidiary.  
The net operating loss carry forward has an indefinite expiration 
period.

   The Corporation has not recognized a deferred tax liability for 
the undistributed earnings of subsidiaries that arose in 1995 and 
prior years because the Corporation currently does not expect those 
unremitted earnings to reverse and become taxable to the Corporation 
in the foreseeable future.  A deferred tax liability will be 
recognized when the Corporation expects that it will recover those 
undistributed earnings in a taxable manner, such as through receipt 
of dividends, net of available foreign tax credits, or sale of the 
investments.  At March 31, 1995, the undistributed earnings of those 
subsidiaries were approximately $22,000,000.

6.  SEGMENT REPORTING

The Corporation is engaged in the business of developing, 
manufacturing and marketing industrial chemicals, supplies and 
related equipment.

<TABLE>
   The following table is a summary of the Corporation's operations 
by geographic area:
<CAPTION>
                                North                 Asia-
(In thousands)                 America    Europe     Pacific   Consolidated
                               --------------------------------------------
                                                   1995
                                                   ----
<S>                             <C>        <C>        <C>       <C>
Net sales to unaffiliated 
   customers:
    Proprietary                 $90,177    $34,490    $38,648   $163,315
                                ========================================
    Total Sales                 $93,866    $41,196    $47,038   $182,100
Cost of goods sold               47,544     24,200     22,315     94,059
Selling, technical and
   administrative expense        40,308     12,311     15,285     67,904
                                ---------------------------------------- 
    Operating profit              6,014      4,685      9,438     20,137
Other income (expense)            1,532     (1,488)    (2,034)    (1,990)
                                ----------------------------------------
    Earnings before 
       income taxes <F1>          7,546      3,197      7,404     18,147
Income taxes                      3,476      1,458      2,071      7,005
                                ----------------------------------------
    Net earnings <F1>           $ 4,070    $ 1,739    $ 5,333   $ 11,142
                                ========================================
Identifiable assets             $67,780    $21,943    $33,582   $123,305
                                ========================================

                                                 1994 <F2>
                                                 ----
Net sales to unaffiliated 
   customers:
    Proprietary                 $68,864    $31,469   $30,268    $130,601
                                ========================================
    Total Sales                 $73,861    $37,951   $38,214    $150,026
Cost of goods sold               35,538     22,416    18,960      76,914
Selling, technical and 
   administrative expense        32,785     13,118    14,160      60,063
                                ----------------------------------------
    Operating profit              5,538      2,417     5,094      13,049
Other income (expense)              268     (1,478)      585        (625)
                                ----------------------------------------
    Earnings before 
       income taxes <F1>          5,806        939     5,679      12,424
Income taxes                      2,843        683     1,127       4,653
                                ----------------------------------------
    Net earnings <F1>           $ 2,963    $   256   $ 4,552    $  7,771
                                ========================================
Identifiable assets             $56,708    $19,942   $29,217    $105,867
                                ========================================

                                                 1993 <F2>
                                                 ----
Net sales to unaffiliated 
   customers:  
    Proprietary                 $66,822    $35,406   $27,904    $130,132
                                ========================================
    Total Sales                 $74,068    $45,042   $37,214    $156,324
Cost of goods sold               38,363     27,372    18,165      83,900
Selling, technical and 
   administrative expense        30,472     14,197    12,211      56,880
                                ----------------------------------------
    Operating profit              5,233      3,473     6,838      15,544
Other income (expense)              880     (2,637)   (1,449)     (3,206)
                                ----------------------------------------
    Earnings before 
        income taxes              6,113        836     5,389      12,338
Income taxes                      3,076        177     1,398       4,651
                                ----------------------------------------
    Net earnings                $ 3,037    $   659   $ 3,991    $  7,687
                                ========================================
Identifiable assets             $53,645    $24,796   $28,732    $107,173
                                ========================================
<FN>
<F1>  Before the cumulative effect of accounting changes which 
resulted in one-time after tax charges of $371,000 ($0.12/share) in 
1995 and $2,082,000 ($0.58/share in 1994).

<F2>  Certain amounts in the 1994 and 1993 geographic segment 
presentations have been reclassified to conform with the 1995 
presentation.
</TABLE>

7.  LONG-TERM OBLIGATIONS
<TABLE>
Long-term obligations at March 31 consisted of the following:
<CAPTION>
(In thousands)                                  1995            1994
                                              ----------------------
<S>                                           <C>             <C>
Term loan, variable interest
   (7.5% at March 31, 1995), due
   in quarterly installments to 2,001         $21,875         $   -  

Note payable, variable interest                   -               450

Debenture, 3.5% interest due in
   annual installments to 1999                    607             649
Other, due in varying amounts 
   to 1999                                        160             252
                                              -----------------------
Total long-term obligations                    22,642           1,351
Less current portion                            4,413             429
                                              -----------------------
Long-term portion                             $18,229        $    922
                                              =======================
</TABLE>

<TABLE>
   Minimum future principal payments on long-term obligations 
subsequent to March 31, 1995 are as follows:

(In thousands)
<S>                                          <C>
               1996                          $ 4,413
               1997                            4,385
               1998                            4,349
               1999                            4,288
               2000                            4,166
               2001                            1,041
                                             -------
                   Total                     $22,642
                                             =======
</TABLE>

   The term loan bears interest at a variable rate, which initially 
was equal to the London interbank market rate (LIBOR) plus 1.25 
percentage points.  The Corporation has purchased an interest rate 
cap which limits the LIBOR interest rate payable on the outstanding 
portions of the debt, except for the last $3.1 million.  The maximum 
payable rates increase gradually from 5.81%, initially, to 8.97% 
when the interest rate cap expires.  At March 31, 1995 the 7.5% 
effective interest rate included a LIBOR rate of 6.5% plus 1%.  The 
maximum payable LIBOR rate under the interest rate cap was 6.98%.  
The maximum effective interest rate payable would have been 7.98%.

   Under the term loan, the most restrictive covenants provide that 
dividends to shareholders cannot exceed 50% of net earnings; a 
future business acquisition cannot cause consolidated debt to exceed 
three hundred percent of earnings before interest, taxes, 
depreciation and amortization; the ratio of earnings before income 
taxes to interest expense must be at least 2.5 to 1; the minimum 
consolidated net worth shall be at least $37 million plus one-half 
of consolidated net earnings after October 6, 1994; and the ratio of 
total debt to net worth shall be no greater than 1.2 to 1 during 
calendar year 1995 and .9 to 1 thereafter.

8.  LEASE COMMITMENTS

The Corporation leases certain warehouse space, transportation, 
computer and other equipment.  Contingent rentals are paid for 
warehouse space on the basis of the monthly quantities of materials 
stored and for transportation and other equipment on the basis of 
mileage or usage.  Total rental expense amounted to $4,968,000 in 
1995, $4,126,000 in 1994, and $4,427,000 in 1993 of which $821,000, 
$587,000 and $610,000, respectively, were contingent rentals.  

<TABLE>
   Minimum lease commitments under operating leases for the fiscal 
years subsequent to March 31, 1995 are as follows:

(In thousands)
<S>                                          <C>
               1996                          $2,648
               1997                             766
               1998                             261
               1999                             143
               2000                              31
                                             ------
                   Total                     $3,849
                                             ======
</TABLE>


9.  SHAREHOLDERS' EQUITY
<TABLE>
The following summarizes the changes in shareholders' equity accounts 
for each of the three years in the period ended March 31,1995:

(In thousands, except share data)
<CAPTION>
                           Common Stock                                                         Total
                           ------------   Additional            Cumulative    Treasury Stock    Share-
                                  Stated   Paid-in    Retained  Translation   --------------    holders
                          Shares   Value   Capital    Earnings  Adjustment    Shares    Cost    Equity
- -------------------------------------------------------------------------------------------------------
<S>                     <C>        <C>    <C>         <C>         <C>      <C>        <C>       <C>
Balance March 31, 1992  4,095,648  $4,096 $  464      $65,943     $2,147     530,648  $(11,600) $61,050
Stock options 
  exercised                 2,382       2    150                                                    152
Net earnings                                            7,687                                     7,687
Cash dividends 
  $.60 per share                                       (2,139)                                   (2,139)
Foreign currency
  translation
  adjustment                                                      (1,569)                        (1,569)
                        -------------------------------------------------------------------------------

Balance March 31, 1993  4,098,030   4,098    614       71,491        578     530,648   (11,600)  65,181
Stock options 
  exercised                   500       1    220                                                    221
Net earnings                                            5,689                                     5,689
Cash dividends 
  $.60 per share                                       (2,141)                                   (2,141)
Foreign currency
  translation
  adjustment                                                        (781)                          (781)
                        --------------------------------------------------------------------------------

Balance March 31, 1994  4,098,530   4,099    834       75,039       (203)    530,648   (11,600)  68,169
Stock options 
  exercised                37,550      37    842                                                    879
Net earnings                                           10,771                                    10,771 
Cash dividends 
  $.60 per share                                       (1,767)                                   (1,767)
Foreign currency
  translation
  adjustment                                                       1,754                          1,754
Treasury stock purchase                                                      862,899   (26,152) (26,152)
                        --------------------------------------------------------------------------------
Balance March 31, 1995  4,136,080  $4,136 $1,676      $84,043     $1,551   1,393,547  $(37,752) $53,654
                        ================================================================================
</TABLE>

   Effective August 1, 1994, the Corporation purchased 851,899 
shares of its common stock at a price of $30 per share pursuant to a 
"Dutch Auction" self tender offer that commenced on June 23, 1994 
(the Offer).  Under the terms of the Offer, the Corporation had 
sought to purchase up to 1,000,000 shares at prices not greater than 
$30 nor less than $25 per share, as specified by the tendering 
shareholders.  The shares purchased pursuant to the Offer represent 
approximately 23.8% of the shares outstanding immediately prior to 
the commencement of the Offer.  The total cost of the Offer, 
including all related fees and expenses, of approximately $26.2 
million was funded primarily by borrowing $25 million on an 
unsecured basis under a six-year term loan which is discussed under 
Note 7 to these consolidated financial statements.

   Separately, the Board of Directors authorized the purchase of up 
to 148,000 shares of the Corporation's common stock to be acquired 
through open market purchases or privately negotiated transactions 
from time to time. During the third quarter of fiscal 1995, 11,000 
shares of common stock were repurchased at $35 per share pursuant to 
this authorization.  Any future repurchases under this authorization 
will depend on various factors, including the market price of the 
shares, the Corporation's business and financial position and 
general economic and market conditions.  Additional shares acquired 
pursuant to such authorization will be held in the Corporation's 
treasury and will be available for the Corporation to issue without 
further shareholder action (except as required by applicable law or 
the rules of any securities exchange on which the share are then 
listed).  Such shares may be used for various Corporate purposes, 
including contributions under existing or future employee benefit 
plans, the acquisition of other businesses and the distribution of 
stock dividends.  At March 31, 1995, there was a balance of such 
outstanding authorizations totaling 137,000 shares.

10.  CONTINGENCIES

The Corporation has been named as a potentially responsible party 
(PRP) by the Environmental Protection Agency in connection with two 
waste sites.  There are many other companies involved at each of 
these sites and the Corporation's participation is minor.  The 
Corporation has recorded its best estimate of liabilities in 
connection with site clean-up based upon the extent of its 
involvement, the number of PRPs and estimates of the total costs of 
the site clean-up.  Though it is difficult to predict the final 
costs of site remediation, management believes that the recorded 
liabilities are reasonable estimates of probable liability and that 
future cash outlays are unlikely to be material to its consolidated 
financial position, results of operations or cash flows.

   The Corporation is a party to a number of lawsuits and claims 
arising out of the ordinary conduct of business.  While the ultimate 
results of the proceedings against the Corporation cannot be 
predicted with certainty, management does not expect that resolution 
of these matters will have a material adverse effect upon its 
consolidated financial position.

   The Corporation's business operations, consist principally of 
manufacture and sale of specialty chemicals, supplies and related 
equipment to customers throughout much of the world.  Approximately 
60% of the business is concentrated with manufacturers of printed 
circuit boards which are used in a wide variety of end-use 
applications, including computers, communications and control 
equipment, appliances, automobiles and entertainment products.  As 
is usual for this business, the Corporation generally does not 
require collateral or other security as a condition of sale, 
choosing, rather, to control credit risk of trade account financial 
instruments by credit approval, balance limitation and monitoring 
procedures.  Management believes that reserves for losses, which are 
established based upon review of account balances and historical 
experience, are adequate.

<PAGE>
        MANAGEMENT'S STATEMENT OF FINANCIAL RESPONSIBILITY

MacDermid, Incorporated (Logo)

                                                245 Freight Street
                                                Waterbury, CT  06702

To The Shareholders
MacDermid, Incorporated

The financial information in this report, including the audited 
consolidated financial statements, has been prepared by management.  
Preparation of consolidated financial statements and related data 
involves the use of judgment.  Accounting principles used in 
preparing consolidated financial statements are those that are 
generally accepted in the United States.

   To safeguard Corporate assets, it is important to have a sound 
but dynamic system of internal controls and procedures that balances 
benefits and costs.  The Corporation employs professional financial 
managers whose responsibilities include implementing and overseeing 
the financial control system, reporting on management's stewardship 
of assets entrusted to it by share owners and performing accurate 
and proper maintenance of the accounts.

   Management has long recognized its responsibility for conducting 
the affairs of the Corporation and its affiliates in an ethical and 
socially responsible manner.  MacDermid, Incorporated is dedicated 
to the highest standards of integrity.  Integrity is not an 
occasional requirement, but a continuing commitment.

   KPMG Peat Marwick LLP conducts an objective, independent review 
of management's fulfillment of its obligations relating to the 
fairness of reported operating results and financial condition.  
Their report for 1995 appears adjacent to this statement.

   The Audit Committee of the Board of Directors, consisting solely 
of Directors independent of MacDermid, maintains an ongoing 
appraisal on behalf of the share owners of the effectiveness of the 
independent auditors and the Corporation's staff of financial and 
operating management with respect to the financial and internal 
controls.


/s/Daniel H. Leever

Daniel H. Leever
President and Chief Executive Officer

<PAGE>
                         INDEPENDENT AUDITORS' REPORT

KPMG Peat Marwick LLP (Logo)
Certified Public Accountants
                                           City Place II
                                           Hartford, CT  06103-4103

The Board of Directors and Shareholders
MacDermid, Incorporated

We have audited the accompanying consolidated balance sheets of 
MacDermid, Incorporated and subsidiaries as of March 31, 1995 and 
1994, and the related consolidated statements of earnings and cash 
flows for each of the years in the three-year period ended March 31, 
1995.  These consolidated financial statements are the 
responsibility of the Company's management.  Our responsibility is 
to express an opinion on these consolidated financial statements 
based on our audits.

   We conducted our audits in accordance with generally accepted 
auditing standards.  Those standards require that we plan and 
perform the audit to obtain reasonable assurance about whether the 
financial statements are free of material misstatement.  An audit 
includes examining, on a test basis, evidence supporting the amounts 
and disclosures in the financial statements.  An audit also includes 
assessing the accounting principles used and significant estimates 
made by management, as well as evaluating the overall financial 
statement presentation.  We believe that our audits provide a 
reasonable basis for our opinion.

   In our opinion, the consolidated financial statements referred 
to above present fairly, in all material respects, the financial 
position of MacDermid, Incorporated and subsidiaries at March 31, 
1995 and 1994 and the results of their operations and their cash 
flows for each of the years in the three-year period ended March 31, 
1995 in conformity with generally accepted accounting principles.

   As discussed in Note 4 to the consolidated financial statements, 
the Company adopted the provisions of the Financial Accounting 
Standards Board's Statement of Financial Accounting Standards No. 
112, "Employers' Accounting for Postemployment Benefits" in 1995, 
and Statement of Financial Accounting Standards No. 106, "Employers' 
Accounting for Postretirement Benefits Other Than Pensions" in 1994.



                                   /s/KPMG Peat Marwick LLP

                                   /s/KPMG Peat Marwick LLP


May 12, 1995

<PAGE>
<TABLE>
                         SELECTED FINANCIAL DATA
                        SELECTED QUARTERLY RESULTS
                                (UNAUDITED)

(In thousands, except per share amounts)
                                           1995 by Quarters
                           ----------------------------------------------
<CAPTION>
                            June    September  December  March    Total
                           ----------------------------------------------
<S>                        <C>        <C>      <C>      <C>      <C>
Net sales                  $42,587    $46,498  $44,547  $48,468  $182,100
Gross profit                21,262     21,779   21,684   23,316    88,041
Net earnings                 2,799<F2>  2,667    2,637    2,668    10,771<F2>
Primary earnings 
  per share<F1>              $0.78<F2>  $0.85    $0.92    $0.92     $3.43<F2>

                                          1994 by Quarters
                           ----------------------------------------------
                            June    September  December  March    Total
                           ----------------------------------------------
Net sales                  $39,850    $37,755  $34,814  $37,607  $150,026
Gross profit                19,500     17,979   16,806   18,827    73,112
Net earnings                  (184)<F2> 1,860    1,477    2,536     5,689<F2>
Earnings per share          $(0.05)<F2> $0.52    $0.42    $0.71     $1.60<F2>
<FN>

<F1>  Fiscal 1995 was the first year in which the dilutive effect of 
options granted was large enough to report. 

<F2>  After cumulative effect of accounting changes which resulted 
in one-time after tax charges of $371,000 ($0.12/share) in 1995 and 
$2,082,000 ($0.58/share) in 1994.
</TABLE>
- ---------------------------------------------------------------------------
<TABLE>
                              MARKET RANGE TRADING RECORD

                           Fiscal 1995                   Fiscal 1994
                         ------------------             -----------------
<CAPTION>
                          High      Low                  High       Low
QUARTER                  ------------------             -----------------
<S>                      <C>         <C>                <C>        <C>
June                     29 1/2      24                 31         25 1/4
September                36 1/2      29                 28 1/2     26 3/4
December                 42          34                 28 3/4     24 1/2
March                    44 1/2      36 1/2             27 1/4     24 1/2

Closing price March 31          43                              26
<FN>
Source:  Nasdaq Stock Market Monthly Statistical Report
</TABLE>

<TABLE>
                                   DIVIDEND RECORD
                     Fiscal 1995                        Fiscal 1994
               ---------------------------     ----------------------------
<CAPTION>
               Record   Payable    Amount        Record   Payable   Amount
QUARTER         Date     Date     Declared        Date     Date    Declared
               ---------------------------     ----------------------------
<S>           <C>       <C>        <C>         <C>       <C>        <C>
June           6/15/94   7/1/94    $0.15        6/15/93   7/1/93    $0.15
September      9/15/94  10/3/94    $0.15        9/15/93  10/1/93    $0.15
December      12/15/94   1/3/95    $0.15       12/15/93   1/3/94    $0.15
March          3/15/95   4/3/95    $0.15        3/15/94   4/1/94    $0.15
</TABLE>

<PAGE>
                           CORPORATE INFORMATION
DIRECTORS:

Harold Leever, Chairman of the Board
Daniel H. Leever, President and Chief Executive Officer
Donald G. Ogilvie, Executive Vice President, 
   American Bankers Association
James C. Smith, Chairman of the Board and Chief Executive Officer, 
   Webster Financial Corporation
Thomas W. Smith, President of Prescott Investors, Inc.
Walter F. Torrance, Jr., Partner, Carmody & Torrance, Attorneys
Robert F. Welzien, Chairman and Chief Executive Officer of 
   LISA Products Corporation
Francis M. White, Retired Chairman of the Board, 
   Bank of Boston Connecticut

OFFICERS:

Harold Leever, Chairman of the Board
Daniel H. Leever, President and Chief Executive Officer

VICE PRESIDENTS:

Charles T. Cobb
Terrence C. Copeland
David A. Erdman
John J. Grunwald
Peter E. Kukanskis
Gary B. Larson
Michael A. Pfaff

OTHER OFFICERS:

Gregory M. Bolingbroke, Corporate Controller
John L. Cordani, Corporate Secretary
Sharon J. Stone, Assistant Treasurer

CORPORATE HEADQUARTERS:

245 Freight Street
Waterbury, Connecticut 06702
(203) 575-5700

AUDITORS:

KPMG Peat Marwick LLP

REGISTRAR OF STOCK AND TRANSFER AGENT:

Harris Trust Company of New York


SEC FORM 10-K:

The Annual Report and the SEC Form 10-K report are 
available without charge by written request to:
   Corporate Secretary
   MacDermid, Incorporated
   245 Freight Street
   Waterbury, CT  06702

DIVIDEND REINVESTMENT PLAN:

A systematic investment service is available to all MacDermid 
shareholders.  The service permits investment of MacDermid, 
Incorporated dividends and voluntary cash payments in additional 
shares of MacDermid stock.

Please direct any inquiries to:
    Harris Trust Company of New York
    c/o Harris Trust and Saving Bank
    Dividend Reinvestment Department
    P.O. Box A3309
    Chicago, IL  60690

SHAREHOLDERS' QUESTIONS:

Shareholders with questions concerning non-receipt of dividend 
checks, transfer requirements, registration and address changes, 
or who need a duplicate 1099 statement, should write to:

    Harris Trust Company of New York
    c/o Harris Trust and Savings Bank
    111 West Monroe, P.O. Box 755
    Chicago, IL  60690

MARKET & DIVIDEND INFORMATION:

The common shares of MacDermid, Incorporated are traded on 
the Nasdaq Stock Market (Symbol:  MACD).  Price and shares 
traded are listed in principal daily newspapers and are 
supplied by Nasdaq.  Approximate number of Holders as of 
May 31, 1995 - 800. CUSIP-554273 102.

ANNUAL MEETING:

The Annual Meeting of Shareholders will be held on Thursday, 
July 20, 1995 at 3:30 p.m., at the Holiday Inn Waterbury, 
63 Grand Street, Waterbury, CT.

<PAGE>
LOCATIONS IN THE AMERICAS:

United States:  Waterbury, CT; New Hudson, MI; Cincinnati, OH; Ferndale, 
   Dallas, TX
Canada:  MacDermid Chemicals, Inc.

LOCATIONS WORLDWIDE:

Australia:  MacDermid Australia Branch
Benelux:  MacDermid Benelux, B.V.
England:  MacDermid G.B., Ltd.
France:  MacDermid France, S.A.
Germany:  MacDermid GmbH
Hong Kong:  MacDermid Asia Ltd; MacDermid Hong Kong, Ltd.
Israel:  MacDermid Israel Ltd.
Italy:  MacDermid Italiana SRL
Japan:  Nippon MacDermid Co. Ltd.
Korea:  MacDermid Korea Ltd.
New Zealand:  MacDermid New Zealand, Ltd.
Rep. of South Africa:  MacDermid S.A. (PTY) Ltd.
Singapore: MacDermid Singapore, Pte Ltd.
Spain:  MacDermid Espanola, S.A.
Switzerland:  MacDermid Suisse, S.A.
Taiwan:  MacDermid Taiwan, Ltd.

AFFILIATE:

Hollmuller America, Inc.:  Waterbury, CT



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission